Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypertension: HELP
Dr. Ja Staessen
Based on 221 articles published since 2007
||||
Expertise Level
The expertise of Dr. Ja Staessen ranks in the
  • Top 0.0093%
  • ... of 183,560 published authors worldwide on Hypertension
  • ... from 2007 through 2018
  • ... based on contributions to 221 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Staessen, J   ·   Staessen, Ja   ·   Staessen, Jan Albert   ·   Staessen, Jan   ·   Staessen, Jan A   ·   Staessen, J A
Work Locations
Details
Confirmed:
(May 2014) 
  Katholieke Universiteit Leuven      
2017
  • Division of Nephrology and Hypertension, Department of Medicine, University of California, San Diego, La Jolla. · Imperial Valley Family Care Medical Group, El Centro, California. · Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, Canada. · Department of Biostatistics and Bioinformatics, MedStar Health Research Institute, Hyattsville, Maryland. · Georgetown-Howard Universities Center for Clinical and Translational Research, Hyattsville, Maryland. · Department of Public Health and Primary Care, University of Cambridge, Cambridge, England. · School of Biological and Population Health Sciences, Oregon State University, Corvallis. · Division of Nephrology, Department of Medicine, University of California, San Francisco. · Division of Nephrology and Hypertension, Department of Internal Medicine, University of Utah, Salt Lake City. · Medical Service, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah. · Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. · Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, England. · Istituto Auxologico Italiano, Center of Clinical Physiology and Hypertension, Università Degli Studi di Milano, Milan, Italy. · School of Public Health, Imperial College London, London, England. · Care of the Elderly, Imperial College London, London, England. · Research Unit Hypertension and Cardiovascular Epidemiology, Katholieke Universiteit Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Research and Development Group VitaK, Maastricht University, Maastricht, the Netherlands. · Division of Preventive Medicine, Department of Family Medicine and Public Health, University of California, San Diego, La Jolla. · Nephrology Section, Veterans Affairs San Diego Healthcare System, La Jolla, California. · Pubmed 28873137
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · R&D Group VitaK, Maastricht University, Maastricht, The Netherlands. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Department of Social Pharmacy and Public Health, Showa Pharmaceutical University, Tokyo, Japan. · Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Eamon Dolan, Stroke and Hypertension Unit, Connolly Hospital, Blanchardstown, Co, Dublin, Ireland. · Conway Institute, University College Dublin, Dublin, Ireland. · Pubmed 28052877
  • Department of Nephrology and Hypertension, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Internal Medicine and Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway. · Department of Radiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Section for Interventional Cardiology, Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, UK. · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · Cardiology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Radiology, Glasgow Royal Infirmary, Glasgow, UK. · Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Nephrology and Hypertension, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Pubmed 28271154
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (C.-S.S., Y.-B.C., Q.-H.G., F.-K.L., Q.-F.H., J.-G.W., Y.L.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (F.-F.W., W.-Y.Y., L.T., J.A.S.); and R & D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (C.-S.S., Y.-B.C., Q.-H.G., F.-K.L., Q.-F.H., J.-G.W., Y.L.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (F.-F.W., W.-Y.Y., L.T., J.A.S.); and R & D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · Pubmed 27821618
  • a Department of Medicine , Imperial College London , London , UK. · b Department of Medicine, Brighton and Sussex Medical School , Brighton , UK. · d Department of Mathematics, University of Brighton , Brighton , UK. · e Department of Neurology, The George Institute for Global Health , Sydney , Australia. · g Division of Medicine Care of the Elderly Oulu City Hospital and Institute of Health Sciences (Geriatrics), Oulu University , Oulu , Finland. · f Department of Medicine, University of Leuven , Leuven , Belgium. · c Department of Elderly Medicine, Brighton and Sussex University Hospital , Brighton, UK. · Pubmed 27546817
2016
  • Università Vita Salute San Raffaele, Chair of Nephrology; IRCCS San Raffaele Scientific Institute, Genomics of Renal Disease and Hypertension Unit, Via Olgettina 60, 20132, Milan, Italy. · CVie Therapeutics Limited, Taipei, Taiwan. · Italian National Centre of Research, Institute of Biomedical Technologies, Segrate, Milan, Italy. · Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · R&D Group VitaK, Maastricht University, Maastricht, The Netherlands. · Università Vita Salute San Raffaele, Chair of Nephrology; IRCCS San Raffaele Scientific Institute, Genomics of Renal Disease and Hypertension Unit, Via Olgettina 60, 20132, Milan, Italy. · CVie Therapeutics Limited, Taipei, Taiwan. · Pubmed 26915067
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Cardiology, Ullevaal University Hospital, University of Oslo, Oslo, Norway. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · R & D VitaK Group, Maastricht University, Maastricht, The Netherlands. · Paris-Descartes University, F-75005, Paris, France. · Assistance Publique-Hôpitaux de Paris, Hypertension Unit, Hôpital Européen Georges Pompidou, F-75015, Paris, France. · Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigations Cliniques 1418, F-75015, Paris, France. · Pubmed 26739586
  • Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine, Irvine, California. Electronic address: · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Gentofte, Denmark. · Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden; Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark. · Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom. · Institute of Internal Medicine, Novosibirsk, Russian Federation. · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland. · Department of Medicine, University of Padua, Padua, Italy. · Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay. · Faculty of Medicine, Charles University, Pilsen, Czech Republic. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands. · Pubmed 27810041
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Department of Development and Regeneration, University of Leuven, Leuven, Belgium. · Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Department of Pharmacology, Maastricht University, Maastricht, The Netherlands. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · R & D Group VitaK, Maastricht University, Maastricht, The Netherlands. · Pubmed 27383509
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (F.-F.W., Z.-Y.Z, L.T., W.-Y.Y, L.J., N.C., Y.-M.G., T.K., J.A.S.), Department of Development and Regeneration (K.A.), Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences (P.V.), University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and R&D Group VitaK (J.A.S.), Maastricht University, Maastricht, The Netherlands. · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (F.-F.W., Z.-Y.Z, L.T., W.-Y.Y, L.J., N.C., Y.-M.G., T.K., J.A.S.), Department of Development and Regeneration (K.A.), Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences (P.V.), University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and R&D Group VitaK (J.A.S.), Maastricht University, Maastricht, The Netherlands. · Pubmed 27324224
  • Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan Japan Development and Medical Affairs, GlaxoSmithKline KK, Tokyo, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan. · Embassy of Japan, Rome, Italy. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium R&D VitaK Group, Maastricht University, Maastricht, The Netherlands. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan · Pubmed 27009620
  • a Department of Cardiology, The First Affiliated Hospital , Nanjing Medical University , Nanjing , PR China ; · b Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences , University of Leuven , Leuven , Belgium ; · c Department of Internal Medicine, College of Health Sciences , University of Abuja , Abuja , Nigeria ; · d The Health Bureau of Gaoyou , Gaoyou , PR China ; · e R&D VitaK Group , Maastricht University , Maastricht , The Netherlands. · Pubmed 26581308
  • Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; · Department of Cardiology, Shandong Provincial Hospital of Traditional Chinese Medicine, Jinan, Shandong, China; · Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; R & D VitaK Group, Maastricht University, Maastricht, The Netherlands. · Pubmed 26150543
  • National University of Ireland Galway, Galway, Ireland · Munich and Friedrich Alexander University, Erlangen-Nuremberg, Germany. · North-West University, Potchefstroom, South Africa. · University of Leuven, Leuven, Belgium. · Fundación Oftalmológica de Santander, Floridablanca, Colombia. · Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · McMaster University, Hamilton, ON, Canada. · Centre Hospitalier Universitaire de Poitiers, Poitiers, France. · Pubmed 27974028
2015
  • First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. Electronic address: · Pubmed 25704347
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. Electronic address: · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Department of General Internal Medicine, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway; Department of Cardiology, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway. · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Nephrology, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway. · Department of Cardiology, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25601357
  • 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25319600
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. Electronic address: · Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 26565110
  • Department of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 26506526
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 26063667
  • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Hygiene and Public health, Teikyo University School of Medicine, Tokyo, Japan. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Department of Environmental Health Sciences, Tohoku University Graduate School of Medicine, Sendai, Japan. · Department of Development and Environmental Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. · Department of Pharmacy, Tohoku University Hospital, Sendai, Japan. · Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan. · Professor Emeritus, Tohoku University, Sendai, Japan. · Pubmed 25971628
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (L.Z., Y.L., F.-F.W., Y.-Y.K., S.W., T.-Y.X., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (L.Z., Y.L., F.-F.W., Y.-Y.K., S.W., T.-Y.X., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25870194
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Kapucijnenvoer 35, Box 7001, BE-3000 Leuven, Belgium. · Pubmed 25752835
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Y.-M.G., Y.-P.L., L.T., T.P., Z.Z., T.K., J.A.S.) and Center for Molecular and Vascular Biology (P.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (S.W., L.Z., F.-F.W., Y.-Y.K., Q.-F.H.,C.-S.S.,Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and VitaK Research and Development (J.A.S.), Maastricht University, Maastricht, The Netherlands. · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Y.-M.G., Y.-P.L., L.T., T.P., Z.Z., T.K., J.A.S.) and Center for Molecular and Vascular Biology (P.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (S.W., L.Z., F.-F.W., Y.-Y.K., Q.-F.H.,C.-S.S.,Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and VitaK Research and Development (J.A.S.), Maastricht University, Maastricht, The Netherlands. · Pubmed 25712718
  • Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland; Department of Medicine, Turku University Hospital, Turku, Finland; · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland; · Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan; · Department of Public Health, Tohoku University Graduate School of Medicine, Sendai, Japan; · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25399016
  • Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands. · The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 25339295
  • The Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · The Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · The Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Epidemiology, University of Maastricht, Maastricht, The Netherlands. · Pubmed 25241047
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25827470
2014
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium Research and Development Group VitaK, Maastricht University, Maastricht, The Netherlands · Pubmed 25246482
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan; · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique and Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, Netherlands. · Pubmed 25122867
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands. · Pubmed 25090617
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium Nephrology Department, Grand Hôpital de Charleroi, Gilly, Belgium. · Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24876198
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; · Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; Nephrology Department, Grand Hôpital de Charleroi, Gilly Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven Belgium; · Division of Nephrology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven Belgium; Department of Epidemiology, Maastricht University, Maastricht The Netherlands. · Pubmed 24795400
  • Institute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Lausanne, Switzerland. · Service of Nephrology, University Hospital of Lausanne, Lausanne, Switzerland. · Service of Nephrology, Department of Specialties, University Hospital of Geneva, Geneva, Switzerland. · Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland. · Institute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Lausanne, Switzerland; Unit of Population Epidemiology, University Hospital of Geneva, Geneva, Switzerland. · Department of Cardiology, University Hospital of Geneva, Geneva, Switzerland. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Community Medicine and Primary Care and Emergency Medicine, University Hospital of Geneva, Geneva, Switzerland. · Pubmed 24663506
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Department of Internal Medicine, Division of Hypertension, University Medical Centre Ljubljana, Slovenia. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Steno Diabetes Center, Gentofte and Research Centre for Prevention and Health, Gentofte, Denmark. · Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark. · Copenhagen University Hospital, Copenhagen, Denmark. · Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom. · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland. · Department of Medicine, University of Padua, Padua, Italy. · Institute of Internal Medicine, Novosibirsk, Russian Federation. · Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. · Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay. · Faculty of Medicine, Charles University, Pilsen, Czech Republic. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Center for Epidemiological Studies and Clinical Trials and. · Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Department of Epidemiology, Maastricht University, Maastricht, Netherlands · Pubmed 24572704
  • Steno Diabetes Centre, Gentofte and Research Centre for Prevention and Health, Glostrup, Denmark. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · 1] Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiantong University School of Medicine, Shanghai, China [2] Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiantong University School of Medicine, Shanghai, China. · Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · 1] Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. · Department of Health Sciences, Shiga University of Medical Sciences, Otsu, Japan. · Copenhagen University Hospital, Copenhagen, Denmark. · Addenbrook's Hospital, Cambridge University Hospitals, Cambridge, UK. · First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Kra-ków, Poland. · Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy. · Institute of Internal Medicine, Novosibirsk, Russian Federation. · The Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay. · Faculty of Medicine, Charles University, Pilsen, Czech Republic. · Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiantong University School of Medicine, Shanghai, China. · The Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · 1] Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] The Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24430701
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium. · Department of Pharmacology, Maastricht University, Maastricht, The Netherlands. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24152823
  • 1] Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium [2] Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Faculté de Médecine, Université Paris Descartes, Paris, France. · Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands. · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · Third Department of Internal Medicine, General Faculty Hospital, Prague, Czech Republic. · Department of Cardiology, Ullevål University Hospital, University of Oslo, Oslo, Norway. · BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. · Hypertension Unit, Geneva University Hospital, Geneva, Switzerland. · Service of Nephrology, Lausanne University Hospital, Lausanne, Switzerland. · Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24067345
  • Studies Coordinating Center, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pole of the Cardiovascular Research, Institut de Recherche Expérimentale et Clinique and Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 24842938
2011
  • The Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Research, University of Leuven, Leuven, Belgium. · Pubmed 21235787
2010
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, Block d, Level 00, Box 7001, B-3000 Leuven, Belgium. · Pubmed 20212274
2008
  • Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, University Hospital Maastricht, Maastricht, The Netherlands. · Pubmed 19020427
  • Department of Cardiovascular Diseases, Division of Hypertension and Cardiovascular Rehabilitation, Studies Coordinating Centre, University of Leuven, Leuven, Belgium. · Pubmed 18496288
2007
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17556887
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17283254
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Campus Gasthuisberg, University of Leuven, B 3000 Leuven, Belgium. · Pubmed 17467493
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17760215
2017
  • aDepartment of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Bern, Switzerland bMount Sinai Icahn School of Medicine, New York, New York, USA cJagiellonian University Krakow, Kraków, Poland dDepartment of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Brescia, Italy eService de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland fDepartment of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, Washington gHeart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine, California, USA hDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland iDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan jDepartment of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway kCardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA lDepartment of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, Paris, France mHypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, Canada nDepartment of Heart Diseases, University of Bergen, Haukeland Hospital, Bergen, Norway oUniversity of Milano-Bicocca pIRCCS Istituto Auxologico Italiano, Milan, Italy qDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland rHypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington, District of Columbia, USA sDepartment of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano tDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy uImperial Clinical Trials Unit, Imperial College London, London, UK vHospital Clinico Unviersitario de Valencia, Valencia wDepartment of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain xDepartment of Medicine, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Québec, Canada yDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany zDivision of Nephrology and Hypertension, Department of Medicine aaAmerican Society of Hypertension, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA bbInternational Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London - Hammersmith Campus, London, UK ccDiabetes and Cardiovascular Center, University of Missouri School of Medicine ddDepartment Service, Harry S Truman Memorial Veterans Hospital eeDepartment of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri, USA ffUniversity of Leuven, Leuven, Belgium ggDepartment of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China hhSUNY Downstate Medical Center, Brooklyn, New York, USA iiUniversity College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, London, UK jjDepartment of Medicine, Masstricht University Medical Center, Maastricht University, Maastricht, the Netherlands. · Pubmed 28657972
  • Departments of Pediatrics and Neonatology (A.R., E.L.) and Laboratory Medicine (J.C., S.P.), University Hospitals Leuven, Belgium; KU Leuven Department of Development and Regeneration (A.R., E.L., K.A.) and Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (Z.-Y.Z., N.C., F.-F.W., L.J., T.K., J.A.S.), University of Leuven, Belgium; Department of Sociology, Vrije Universiteit Brussel, Belgium (T.P. v.T.); R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.); and Intensive Care and Department of Pediatric Surgery, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands (K.A.). · Departments of Pediatrics and Neonatology (A.R., E.L.) and Laboratory Medicine (J.C., S.P.), University Hospitals Leuven, Belgium; KU Leuven Department of Development and Regeneration (A.R., E.L., K.A.) and Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (Z.-Y.Z., N.C., F.-F.W., L.J., T.K., J.A.S.), University of Leuven, Belgium; Department of Sociology, Vrije Universiteit Brussel, Belgium (T.P. v.T.); R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.); and Intensive Care and Department of Pediatric Surgery, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands (K.A.). · Pubmed 28115515
  • From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L.); Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine (S.S.F.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland (E.O.); and R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L.); Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine (S.S.F.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland (E.O.); and R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · Pubmed 28847889
  • From the Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (J.M., G.E.M.); Department of Biomedical Sciences, University of Texas Rio Grande Valley School of Medicine, Brownsville (G.E.M.); Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.A., Y.I.); Studies Coordinating Centre, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Department of Medicine, University of Padua, Italy (E.C.); the Steno Diabetes Center Copenhagen, Gentofte and RCPH, Centre for Health, Capital Region of Denmark, Denmark (T.W.H.); KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.J., T.K., L.T., J.A.S.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Denmark (J.J.); The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.K.J., K.S.S.); Research Unit Hypertension and Cardiovascular Epidemiology, Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., J.-G.W.); Institute of Internal and Preventive Medicine, Novosibirsk, Russia (T.K., S.M., Y.N.); and R & D Group VitaK, Maastricht University, The Netherlands (JAS). · From the Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (J.M., G.E.M.); Department of Biomedical Sciences, University of Texas Rio Grande Valley School of Medicine, Brownsville (G.E.M.); Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.A., Y.I.); Studies Coordinating Centre, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Department of Medicine, University of Padua, Italy (E.C.); the Steno Diabetes Center Copenhagen, Gentofte and RCPH, Centre for Health, Capital Region of Denmark, Denmark (T.W.H.); KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.J., T.K., L.T., J.A.S.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Denmark (J.J.); The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.K.J., K.S.S.); Research Unit Hypertension and Cardiovascular Epidemiology, Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., J.-G.W.); Institute of Internal and Preventive Medicine, Novosibirsk, Russia (T.K., S.M., Y.N.); and R & D Group VitaK, Maastricht University, The Netherlands (JAS). · Pubmed 28483916
  • aDivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical CentrebCAPHRI School for Public Health and Primary CarecDepartment of Epidemiology, Maastricht UniversitydDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The NetherlandseResearch Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, Studies Coordinating Centre, University of Leuven, Leuven, BelgiumfDepartment of Internal Medicine, Maasticht University Medical CentergCARIM School for Cardiovascular Diseases, Maastricht University Medical CentrehCARIM School for Cardiovascular Diseases, and MaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, The Netherlands. · Pubmed 28355168
2016
  • From the Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (A.P., E.B.); Department of Medical Sciences, Internal Medicine and Hypertension Division, AOU Città della Salute e della Scienza, Turin, Italy (F.R., E.B.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.); Paris-Descartes University, F-75005 Paris, France (M.A.); Assistance Publique-Hôpitaux de Paris, Hypertension Unit, Hôpital Européen Georges Pompidou, F-75015 Paris, France (M.A.); Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigations Cliniques 1418, F-75015 Paris, France (M.A.); Department of Cardiology (S.E.K.) and Department of Nephrology (A.H.), Ullevaal University Hospital, University of Oslo, Oslo, Norway; and Clinical Chemistry Department, Cliniques Universitaires St Luc, Brussels, Belgium; Louvain Center for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium (P.W, A.C.). · From the Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (A.P., E.B.); Department of Medical Sciences, Internal Medicine and Hypertension Division, AOU Città della Salute e della Scienza, Turin, Italy (F.R., E.B.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.); Paris-Descartes University, F-75005 Paris, France (M.A.); Assistance Publique-Hôpitaux de Paris, Hypertension Unit, Hôpital Européen Georges Pompidou, F-75015 Paris, France (M.A.); Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigations Cliniques 1418, F-75015 Paris, France (M.A.); Department of Cardiology (S.E.K.) and Department of Nephrology (A.H.), Ullevaal University Hospital, University of Oslo, Oslo, Norway; and Clinical Chemistry Department, Cliniques Universitaires St Luc, Brussels, Belgium; Louvain Center for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium (P.W, A.C.). · Pubmed 27296995
  • From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.). · From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.). · Pubmed 26711735
  • aDivision of Rheumatology, Department of Internal Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre+, Maastricht, The Netherlands bStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium cFirst Department of Cardiology and Hypertension, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland dInstitute of Internal and Preventive Medicine, Novosibirsk, Russian Federation eDepartment of Clinical and Experimental Medicine, University of Padova, Padova fDepartment of Health Sciences, University of Milan, Milan, Italy gFaculty of Medicine, Charles University, Pilsen, Czech Republic hSchool of Nephrology, Vita-Salute San Raffaele University iInstitute of Biomedical Technologies, Italian National Centre of Research, Milan, Italy jVitaK R & D Group kDepartment of Epidemiology, CAPHRI School for Public Health and Primary Care, CARIM School for Cardiovascular Sciences, and MaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, The Netherlands. · Pubmed 27607461
  • From the Departments of Cardiology, Internal Medicine, and Radiology, Isala Hospital, Zwolle, The Netherlands (M.R.d.J., A.A., P.G., J.J.J.S., P.P.H.M.D., J.-E.H., B.A.A.M.v.H., A.R.R.M., A.E.); Center for Innovation and Strategic Collaboration, St Jude Medical, Inc, Irvine, CA (E.O.Y.L.); Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (A.P.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.); The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S.); and University of Rochester School of Medicine & Dentistry, Arrhythmia Institute of The Valley Health System, New York and Ridgewood, NJ (J.S.S.). · From the Departments of Cardiology, Internal Medicine, and Radiology, Isala Hospital, Zwolle, The Netherlands (M.R.d.J., A.A., P.G., J.J.J.S., P.P.H.M.D., J.-E.H., B.A.A.M.v.H., A.R.R.M., A.E.); Center for Innovation and Strategic Collaboration, St Jude Medical, Inc, Irvine, CA (E.O.Y.L.); Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (A.P.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.); The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S.); and University of Rochester School of Medicine & Dentistry, Arrhythmia Institute of The Valley Health System, New York and Ridgewood, NJ (J.S.S.). · Pubmed 27432864
  • From the Departments of Cardiology, Internal Medicine and Radiology, Isala Hospital, Zwolle, The Netherlands (M.R.d.J., A.F.H., P.G., A.A., J.J.J.S., P.P.H.M.D., A.R.R.M., B.A.A.M.v.H., J.-E.H., A.E.); Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc., Irvine, CA (E.O.Y.L.); The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Departments of Cardiology, Internal Medicine and Radiology, Isala Hospital, Zwolle, The Netherlands (M.R.d.J., A.F.H., P.G., A.A., J.J.J.S., P.P.H.M.D., A.R.R.M., B.A.A.M.v.H., J.-E.H., A.E.); Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc., Irvine, CA (E.O.Y.L.); The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 27113046
  • From the Pole of Cardiovascular Research (AP, LE, SH), Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium; Cardiology Department (AP, GN), Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; Human Molecular Genetics (LE, AM, MV), de Duve Institute, Université catholique de Louvain, Brussels, Belgium; Studies Coordinating Centre (YJ, W-YY, JAS), Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Population Health and Optimal Health Practices Research Unit (GN), CHU de Québec Research Centre, Québec, Canada; Pôle de recherche en Endocrinologie (DG), Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; Department of Laboratory Medicine (DG), Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; and Research and Development VitaK Group (JAS), Maastricht University, Maastricht, The Netherlands. · Pubmed 27082544
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.N.O., L.T., A.H., F.-F.W., L.J., J.A.S.); Department of Internal Medicine, Faculty of Clinical Sciences (A.N.O.), Department of Human Physiology (J.O.O.), and Department of Chemical Pathology (M.M.N.), Faculty of Basic Clinical Sciences, College of Health Sciences, University of Abuja, Abuja, Nigeria; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina (L.S.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Department of Health, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., T.O., Y.I.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B., L.L.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O.); and R & D Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.N.O., L.T., A.H., F.-F.W., L.J., J.A.S.); Department of Internal Medicine, Faculty of Clinical Sciences (A.N.O.), Department of Human Physiology (J.O.O.), and Department of Chemical Pathology (M.M.N.), Faculty of Basic Clinical Sciences, College of Health Sciences, University of Abuja, Abuja, Nigeria; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina (L.S.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Department of Health, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., T.O., Y.I.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B., L.L.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O.); and R & D Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 27067719
2015
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (F.-F.W., A.H., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); the Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Copenhagen, Denmark (T.W.H.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (F.-F.W., A.H., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); the Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Copenhagen, Denmark (T.W.H.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25916728
  • From the Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine (S.S.F.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O'B.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Maastricht University, Maastricht, The Netherlands (J.A.S.); and Vitak Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine (S.S.F.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O'B.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Maastricht University, Maastricht, The Netherlands (J.A.S.); and Vitak Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25287401
  • From the Division of Hypertension, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Capital Federal, Argentina (L.S.A., Jessica Barochiner, J.A., P.E.C., G.D.W.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., L.J., A.N.O., J.A.S.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (José Boggia); Department of Internal Medicine, College of Health Sciences, University of Abuja, Abuja, Nigeria (A.N.O.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., K.N., T.O.); Department of Public Health, Tohoku University Graduate School of Medicine, Sendai, Japan (I.T.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (M.K., Y.I.); and R & D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Division of Hypertension, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Capital Federal, Argentina (L.S.A., Jessica Barochiner, J.A., P.E.C., G.D.W.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., L.J., A.N.O., J.A.S.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (José Boggia); Department of Internal Medicine, College of Health Sciences, University of Abuja, Abuja, Nigeria (A.N.O.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., K.N., T.O.); Department of Public Health, Tohoku University Graduate School of Medicine, Sendai, Japan (I.T.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (M.K., Y.I.); and R & D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 26355122
  • aDepartment of Vascular Medicine, Radboud University Medical Centre, Nijmegen bDepartment of Cardiology, Isala Hospital, Zwolle, the Netherlands cDepartment of Cardiovascular Sciences, Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, University of Leuven, Belgium. · Pubmed 26259118
  • aInstitute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Lausanne bDepartment of Cardiology cService of Nephrology, Department of Specialties, University Hospital of Geneva, Geneva dService of Nephrology, University Hospital of Lausanne, Lausanne eDepartment of Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Bern fUnit of Population Epidemiology, University Hospital of Geneva, Geneva, Switzerland gStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium hDepartment of Epidemiology, Maastricht University, Maastricht, the Netherlands iDepartment of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Japan jSwiss Institute of Bioinformatics, University of Lausanne, Lausanne kDepartment of Community Medicine and Primary Care and Emergency Medicine, University Hospital of Geneva, Geneva, Switzerland. · Pubmed 26203966
  • aResearch Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, Studies Coordinating Centre, University of Leuven, Leuven, Belgium bDepartment of Internal Medicine, Division of Cardiology, College of Health Sciences, University of Abuja cDepartment of Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria dTohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan eDepartment of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 26154854
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven , Belgium. · Pubmed 25541647
  • From the Unit of Population Epidemiology, Department of Community Medicine and Primary Care and Emergency Medicine (I.G.), Service of Nephrology, Department of Specialties (B.P., P.-Y.M.), Department of Cardiology (G.E.), and Unit of Hypertension, Department of Community Medicine and Primary Care and Emergency Medicine (I.G., A.P.-B.), University Hospital of Geneva, Switzerland; Institute of Social and Preventive Medicine (IUMSP) (I.G., B.P., G.E., P.V., F.P., M.B.), and Department of Medicine, Service of Nephrology (M.P., M.B.), University Hospital of Lausanne, Switzerland; Department of Nephrology and Hypertension, Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Switzerland (D.A., M.M., B.V.); Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neurosciences, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Hospital of Cery, Prilly, Switzerland (N.A., C.B.E.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University Leuven, Belgium (J.S., Y.G.); Department of Epidemiology, Maastricht University, Maastricht, Netherlands (J.S.); and Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland (C.B.E.). · From the Unit of Population Epidemiology, Department of Community Medicine and Primary Care and Emergency Medicine (I.G.), Service of Nephrology, Department of Specialties (B.P., P.-Y.M.), Department of Cardiology (G.E.), and Unit of Hypertension, Department of Community Medicine and Primary Care and Emergency Medicine (I.G., A.P.-B.), University Hospital of Geneva, Switzerland; Institute of Social and Preventive Medicine (IUMSP) (I.G., B.P., G.E., P.V., F.P., M.B.), and Department of Medicine, Service of Nephrology (M.P., M.B.), University Hospital of Lausanne, Switzerland; Department of Nephrology and Hypertension, Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Switzerland (D.A., M.M., B.V.); Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neurosciences, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Hospital of Cery, Prilly, Switzerland (N.A., C.B.E.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University Leuven, Belgium (J.S., Y.G.); Department of Epidemiology, Maastricht University, Maastricht, Netherlands (J.S.); and Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland (C.B.E.). · Pubmed 25489060
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.H., L.T., Y.-M.G., L.J., Z.-Y.Z., Y.-P.L., J.A.S.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Centre for Environmental Sciences, University of Hasselt, Hasselt, Belgium (T.S.N.); and Research and Development Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.H., L.T., Y.-M.G., L.J., Z.-Y.Z., Y.-P.L., J.A.S.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Centre for Environmental Sciences, University of Hasselt, Hasselt, Belgium (T.S.N.); and Research and Development Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25287397
2014
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Pubmed 23573998
  • From the Institute of Cardiovascular & Medical Sciences (E.M.F.) and School of Medicine (C.G.P., P.O.D.), University of Glasgow, Glasgow, United Kingdom; Studies Coordinating Center, Research Unit Hypertension and Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Director's Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (G.L.J.); Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson (J.P.G.); Department of Cardiology, Ghent University, Ghent, Belgium (M.D.B.); and Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Province of Quebec, Canada (E.L.S.). · From the Institute of Cardiovascular & Medical Sciences (E.M.F.) and School of Medicine (C.G.P., P.O.D.), University of Glasgow, Glasgow, United Kingdom; Studies Coordinating Center, Research Unit Hypertension and Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Director's Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (G.L.J.); Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson (J.P.G.); Department of Cardiology, Ghent University, Ghent, Belgium (M.D.B.); and Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Province of Quebec, Canada (E.L.S.). · Pubmed 25156173
  • aPole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain bDivision of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium cAssistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou and Université Paris Descartes, Paris, France dStudies Coordinating Center, Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, Leuven, Belgium eDepartment of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden fThird Department of Internal Medicine, General Faculty Hospital, Prague, Czech Republic gDepartment of Cardiology, Ullevaal University Hospital, University of Oslo, Oslo, Norway hDepartment of Cardiology, Geneva University Hospitals, Geneva iDepartment of Nephrology, Lausanne University Hospital, Lausanne, Switzerland jBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom kDepartment of Cardiology, Isala Klinieken, Zwolle, the Netherlands lKarolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden mDepartment of Epidemiology, Maastricht University, Maastricht, the Netherlands. · Pubmed 25375391
  • From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK (P.B.M., A.F.D.); Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, PQ, Canada (E.L.S.); Director's Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (G.L.J.); Center for Epidemiological Studies and Clinical Trials, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai, China (J.-G.W.); Department of Cardiology, Ghent University, Ghent, Belgium (M.D.B.); and Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK (P.B.M., A.F.D.); Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, PQ, Canada (E.L.S.); Director's Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (G.L.J.); Center for Epidemiological Studies and Clinical Trials, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai, China (J.-G.W.); Department of Cardiology, Ghent University, Ghent, Belgium (M.D.B.); and Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25245390
  • From the Cardiovascular Research Institut Basel and Department of Medicine, University Hospital Basel, Basel, Switzerland (D.C., S.A., T.S.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., Y.-M.G., T.K., J.A.S.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L., J.-G.W.); Centro de Nefrologìa and Departamento de Fisiopatologìa, Hospital de Clìnicas, Universidad de la Repûblica, Montevideo, Uruguay (J.B.); Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Gentofte, Denmark (T.W.H.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., M.K., T.O., Y.I.); Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden (K.B.-B.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark (J.J.); Department of Health, Science and Technology, Aalborg University, Aalborg, Denmark (C.T.-P.); Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom (E.D.); First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakòw, Poland (K.S.-S., K.K.-J.); Department of Medicine, University of Padova, Padova, Italy (V.T., E.C.); Institute of Internal Medicine, Novosibirsk, Russian Federation (S.M., Y.N.); Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (L.L.); Asoci · Pubmed 25185130
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (K.A., L.T., Y.-M.G., A.H., Y.-P.L., Z.Z., F.-F.W., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., T.O., Y.I.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L., F.-F.W., J.W.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (I.L., J.B., L. Luzardo); Departamento de Informática, Universidad Politécnica de Sinaloa, Mazatlán, Mexico (L.J.M.); Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Denmark (T.W.H.); Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (K.B.-B., L. Lind); Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden (K.B.-B.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.N., T.O.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark (J.J.); Department of Health Science and Technology, Aalborg University, Aalborg, Denmark (C.T.-P.); Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom (E.D.); First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S.-S., K.K.-J.); Department of Medicine, University of Padua, Padua, Italy (E.C.); Institute of Internal Medicine, Novosibirsk, Russian Federation (S.M., Y.N.); Faculty of Medicine, Charles University, Pilsen, Czec · Pubmed 25135185
  • From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.N., K.A., T.O.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (K.A., L.T., A. Hara, J.A.S.); Graduate School of Pharmaceutical Sciences (K.A., Y.I.), Tohoku Medical Megabank Organization (A. Hozawa), and Graduate School of Medicine (I.T.), Tohoku University, Sendai, Japan; Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Medicine, Turku University Hospital, Turku, Finland (T.J.N.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (I.L., J.B.); the Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (A.K., G.S.S.); and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.N., K.A., T.O.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (K.A., L.T., A. Hara, J.A.S.); Graduate School of Pharmaceutical Sciences (K.A., Y.I.), Tohoku Medical Megabank Organization (A. Hozawa), and Graduate School of Medicine (I.T.), Tohoku University, Sendai, Japan; Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Medicine, Turku University Hospital, Turku, Finland (T.J.N.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (I.L., J.B.); the Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (A.K., G.S.S.); and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 24980664
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L., F.-F.W., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., Y.-M.G., Y.-P.L., T.K., J.A.S.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Tohoku University Graduate School of Pharmaceutical Sciences and Medicine, Sendai, Japan (K.A., M.K., T.O., Y.I.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Research Center for Prevention and Health and Steno Diabetes Center, Gentofte, Denmark (T.W.H.); Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden (K.B.-B.); Department of Medicine, Glostrup Hopsital, University of Copenhagen, Copenhagen, Denmark (J.J.); Copenhagen University Hospital, Copenhagen, Denmark (C.-T.P.); Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom (E.D.); First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland (K.S.-S., K.K.-J.); Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy (V.T., E.C.); Institute of Internal Medicine, Novosibirsk, Russian Federation (S.M., Y.N.); Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (L.L.); Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.); Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (L.M., G.E.M.); Faculty · Pubmed 24906822
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven , Leuven , Belgium. · Pubmed 24742341
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Kapucijnenvoer 35, Box 7001, BE-3000 Leuven, Belgium. · Pubmed 24664290
  • Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 24662447
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, block D, Box 7001, BE-3000 Leuven, Belgium. or · Pubmed 24535008
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, Block D, Box 7001, BE-3000 Leuven, Belgium. or · Pubmed 24420553
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven, Kapucijnenvoer 35, Block D, Box 7001, BE-3000 Leuven, Belgium. · Pubmed 24324050
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven , Belgium. · Pubmed 24066715
2013
  • Studies Coordinating Centre, Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 23892701
  • Department of Geriatric Medicine & Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan and Department of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan and Research Institute, National Cerebro & Cardiovascular Research Center, Osaka, Japan and Studies Coordinating Centre, Research Unit Hypertension & Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 24192120
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, Block D, Box 7001, B-3000 Leuven, Belgium. · Pubmed 24060898
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, Campus Sint Rafaël, Kapucijnenvoer 35, Block D, Box 7001, BE-3000 Leuven, Belgium. · Pubmed 24019403
  • 1] Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Hypertension Unit, Department of Internal Medicine, University of Kinshasa Hospital, Kinshasa, Democratic Republic of Congo. · Pubmed 23803591
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Belgium. · Pubmed 23382332
  • Studies Coordinating Center, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 23172933
2012
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 22810950
  • 1] Department of Cardiovascular Diseases, Division of Hypertension and Cardiovascular Rehabilitation, Studies Coordinating Centre, University of Leuven, Leuven, Belgium [2] Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Pubmed 22895063
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, B 3000 Leuven, Belgium. · Pubmed 22789915
  • The Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, University of Leuven, Leuven, Belgium. · Pubmed 22622108
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven Campus Sint Rafaël, Kapucijnenvoer 35, Block D, Box 7001, Leuven BE-3000, Belgium. · Pubmed 22594907
2011
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 21850060
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 21540421
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 21495829
  • Studies Coordinating Centre, Laboratory of Hypertension, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 21228786
2010
  • Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 20613762
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Biomedical Sciences Group, University of Leuven, Leuven, Belgium. · Pubmed 20660518
  • Studies Coordinating Centre, Division of Hypertension and Cardiac Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 20404600
  • Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Studies Coordinating Centre, Leuven, Belgium. · Pubmed 20051905
2009
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 19747655
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Campus Gasthuisberg, Herestraat 49, Leuven, Belgium. · Pubmed 19581508
  • Hypertension and Cardiovascular Rehabilitation Unit, Faculty of Medicine, University of Leuven, Leuven, Belgium. · Pubmed 19225527
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 18787518
2008
  • Department ofCardiovascular Diseases, Division of Hypertension and Cardiovascular Rehabilitation, Studies Coordinating Centre, University of Leuven, Leuven, Belgium. · Pubmed 19001188
  • Hypertension and Cardiovascular Rehabilitation Unit, Faculty of Medicine, University of Leuven, KU Leuven, Belgium. · Pubmed 18756173
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 18551007
  • Department of Cardiovascular Diseases, Division of Hypertension and Cardiovascular Rehabilitation, Studies Coordinating Centre, University of Leuven, Leuven, Belgium. · Pubmed 18496289
  • The Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 18327082
  • Hypertension and Cardiovascular Rehabilitation Unit, Faculty of Medicine, University of Leuven, Belgium. · Pubmed 18039980
2007
  • Studies Coordinating Center, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17765144
  • Hypertension and Cardiovascular Rehabilitation Unit, University of Leuven K.U. Leuven, Leuven, Belgium. · Pubmed 17921823
  • Hypertension and Cardiovascular Rehabilitation Unit, University of Leuven, B-3000 Leuven, Belgium. · Pubmed 17893310
  • Studies Coordinating Centre, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17760218
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17547477
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Research, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17452507
  • Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Studies Coordinating Centre, University of Leuven, Leuven, Belgium. · Pubmed 17301826
  • Studies Coordinating Centre, Laboratory of Hypertension, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Campus Gasthuisberg, University of Leuven, Leuven, Belgium. · Pubmed 17242009
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 221 total) written by Dr. Ja Staessen about Hypertension:

  • Expertise: no longer a sine qua non for guideline authors? 2017
  • Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis. 2017
  • Blood Pressure Measurement Anno 2016. 2017
  • Masked hypertension: understanding its complexity. 2017
  • Does Extremely Low Birth Weight Predispose to Low-Renin Hypertension? 2017
  • Cardiovascular Risk Associated With White-Coat Hypertension: Con Side of the Argument. 2017
  • Prevalence, Treatment, and Control Rates of Conventional and Ambulatory Hypertension Across 10 Populations in 3 Continents. 2017
  • Associations of plasma uric acid and purine metabolites with blood pressure in children: the KOALA Birth Cohort Study. 2017
  • Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiography. 2017
  • Diurnal Blood Pressure Rhythmicity in Relation to Environmental and Genetic Cues in Untreated Referred Patients. 2017
Show List of Full Article Records
Google Searches

Learn more about Dr. Ja Staessen using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Katholieke Universiteit Leuven
Affiliation Timeline What is this?
Katholieke Universiteit Leuven
2017
  • Division of Nephrology and Hypertension, Department of Medicine, University of California, San Diego, La Jolla. · Imperial Valley Family Care Medical Group, El Centro, California. · Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, Canada. · Department of Biostatistics and Bioinformatics, MedStar Health Research Institute, Hyattsville, Maryland. · Georgetown-Howard Universities Center for Clinical and Translational Research, Hyattsville, Maryland. · Department of Public Health and Primary Care, University of Cambridge, Cambridge, England. · School of Biological and Population Health Sciences, Oregon State University, Corvallis. · Division of Nephrology, Department of Medicine, University of California, San Francisco. · Division of Nephrology and Hypertension, Department of Internal Medicine, University of Utah, Salt Lake City. · Medical Service, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah. · Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. · Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, England. · Istituto Auxologico Italiano, Center of Clinical Physiology and Hypertension, Università Degli Studi di Milano, Milan, Italy. · School of Public Health, Imperial College London, London, England. · Care of the Elderly, Imperial College London, London, England. · Research Unit Hypertension and Cardiovascular Epidemiology, Katholieke Universiteit Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Research and Development Group VitaK, Maastricht University, Maastricht, the Netherlands. · Division of Preventive Medicine, Department of Family Medicine and Public Health, University of California, San Diego, La Jolla. · Nephrology Section, Veterans Affairs San Diego Healthcare System, La Jolla, California. · Pubmed 28873137
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · R&D Group VitaK, Maastricht University, Maastricht, The Netherlands. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Department of Social Pharmacy and Public Health, Showa Pharmaceutical University, Tokyo, Japan. · Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Eamon Dolan, Stroke and Hypertension Unit, Connolly Hospital, Blanchardstown, Co, Dublin, Ireland. · Conway Institute, University College Dublin, Dublin, Ireland. · Pubmed 28052877
  • Department of Nephrology and Hypertension, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Internal Medicine and Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway. · Department of Radiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Section for Interventional Cardiology, Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, UK. · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · Cardiology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Radiology, Glasgow Royal Infirmary, Glasgow, UK. · Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands. · Department of Nephrology and Hypertension, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Pubmed 28271154
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (C.-S.S., Y.-B.C., Q.-H.G., F.-K.L., Q.-F.H., J.-G.W., Y.L.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (F.-F.W., W.-Y.Y., L.T., J.A.S.); and R & D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (C.-S.S., Y.-B.C., Q.-H.G., F.-K.L., Q.-F.H., J.-G.W., Y.L.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (F.-F.W., W.-Y.Y., L.T., J.A.S.); and R & D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · Pubmed 27821618
  • a Department of Medicine , Imperial College London , London , UK. · b Department of Medicine, Brighton and Sussex Medical School , Brighton , UK. · d Department of Mathematics, University of Brighton , Brighton , UK. · e Department of Neurology, The George Institute for Global Health , Sydney , Australia. · g Division of Medicine Care of the Elderly Oulu City Hospital and Institute of Health Sciences (Geriatrics), Oulu University , Oulu , Finland. · f Department of Medicine, University of Leuven , Leuven , Belgium. · c Department of Elderly Medicine, Brighton and Sussex University Hospital , Brighton, UK. · Pubmed 27546817
2016
  • Università Vita Salute San Raffaele, Chair of Nephrology; IRCCS San Raffaele Scientific Institute, Genomics of Renal Disease and Hypertension Unit, Via Olgettina 60, 20132, Milan, Italy. · CVie Therapeutics Limited, Taipei, Taiwan. · Italian National Centre of Research, Institute of Biomedical Technologies, Segrate, Milan, Italy. · Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · R&D Group VitaK, Maastricht University, Maastricht, The Netherlands. · Università Vita Salute San Raffaele, Chair of Nephrology; IRCCS San Raffaele Scientific Institute, Genomics of Renal Disease and Hypertension Unit, Via Olgettina 60, 20132, Milan, Italy. · CVie Therapeutics Limited, Taipei, Taiwan. · Pubmed 26915067
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Cardiology, Ullevaal University Hospital, University of Oslo, Oslo, Norway. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · R & D VitaK Group, Maastricht University, Maastricht, The Netherlands. · Paris-Descartes University, F-75005, Paris, France. · Assistance Publique-Hôpitaux de Paris, Hypertension Unit, Hôpital Européen Georges Pompidou, F-75015, Paris, France. · Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigations Cliniques 1418, F-75015, Paris, France. · Pubmed 26739586
  • Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine, Irvine, California. Electronic address: · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Gentofte, Denmark. · Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden; Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark. · Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom. · Institute of Internal Medicine, Novosibirsk, Russian Federation. · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland. · Department of Medicine, University of Padua, Padua, Italy. · Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay. · Faculty of Medicine, Charles University, Pilsen, Czech Republic. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands. · Pubmed 27810041
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Department of Development and Regeneration, University of Leuven, Leuven, Belgium. · Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Department of Pharmacology, Maastricht University, Maastricht, The Netherlands. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · R & D Group VitaK, Maastricht University, Maastricht, The Netherlands. · Pubmed 27383509
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (F.-F.W., Z.-Y.Z, L.T., W.-Y.Y, L.J., N.C., Y.-M.G., T.K., J.A.S.), Department of Development and Regeneration (K.A.), Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences (P.V.), University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and R&D Group VitaK (J.A.S.), Maastricht University, Maastricht, The Netherlands. · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (F.-F.W., Z.-Y.Z, L.T., W.-Y.Y, L.J., N.C., Y.-M.G., T.K., J.A.S.), Department of Development and Regeneration (K.A.), Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences (P.V.), University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and R&D Group VitaK (J.A.S.), Maastricht University, Maastricht, The Netherlands. · Pubmed 27324224
  • Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan Japan Development and Medical Affairs, GlaxoSmithKline KK, Tokyo, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan. · Embassy of Japan, Rome, Italy. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium R&D VitaK Group, Maastricht University, Maastricht, The Netherlands. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan · Pubmed 27009620
  • a Department of Cardiology, The First Affiliated Hospital , Nanjing Medical University , Nanjing , PR China ; · b Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences , University of Leuven , Leuven , Belgium ; · c Department of Internal Medicine, College of Health Sciences , University of Abuja , Abuja , Nigeria ; · d The Health Bureau of Gaoyou , Gaoyou , PR China ; · e R&D VitaK Group , Maastricht University , Maastricht , The Netherlands. · Pubmed 26581308
  • Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; · Department of Cardiology, Shandong Provincial Hospital of Traditional Chinese Medicine, Jinan, Shandong, China; · Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; R & D VitaK Group, Maastricht University, Maastricht, The Netherlands. · Pubmed 26150543
  • National University of Ireland Galway, Galway, Ireland · Munich and Friedrich Alexander University, Erlangen-Nuremberg, Germany. · North-West University, Potchefstroom, South Africa. · University of Leuven, Leuven, Belgium. · Fundación Oftalmológica de Santander, Floridablanca, Colombia. · Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · McMaster University, Hamilton, ON, Canada. · Centre Hospitalier Universitaire de Poitiers, Poitiers, France. · Pubmed 27974028
2015
  • First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. Electronic address: · Pubmed 25704347
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. Electronic address: · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Department of General Internal Medicine, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway; Department of Cardiology, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway. · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Nephrology, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway. · Department of Cardiology, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25601357
  • 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25319600
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. Electronic address: · Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 26565110
  • Department of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 26506526
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 26063667
  • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Hygiene and Public health, Teikyo University School of Medicine, Tokyo, Japan. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Department of Environmental Health Sciences, Tohoku University Graduate School of Medicine, Sendai, Japan. · Department of Development and Environmental Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. · Department of Pharmacy, Tohoku University Hospital, Sendai, Japan. · Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan. · Professor Emeritus, Tohoku University, Sendai, Japan. · Pubmed 25971628
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (L.Z., Y.L., F.-F.W., Y.-Y.K., S.W., T.-Y.X., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (L.Z., Y.L., F.-F.W., Y.-Y.K., S.W., T.-Y.X., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25870194
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Kapucijnenvoer 35, Box 7001, BE-3000 Leuven, Belgium. · Pubmed 25752835
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Y.-M.G., Y.-P.L., L.T., T.P., Z.Z., T.K., J.A.S.) and Center for Molecular and Vascular Biology (P.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (S.W., L.Z., F.-F.W., Y.-Y.K., Q.-F.H.,C.-S.S.,Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and VitaK Research and Development (J.A.S.), Maastricht University, Maastricht, The Netherlands. · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Y.-M.G., Y.-P.L., L.T., T.P., Z.Z., T.K., J.A.S.) and Center for Molecular and Vascular Biology (P.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (S.W., L.Z., F.-F.W., Y.-Y.K., Q.-F.H.,C.-S.S.,Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and VitaK Research and Development (J.A.S.), Maastricht University, Maastricht, The Netherlands. · Pubmed 25712718
  • Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland; Department of Medicine, Turku University Hospital, Turku, Finland; · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland; · Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan; · Department of Public Health, Tohoku University Graduate School of Medicine, Sendai, Japan; · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25399016
  • Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands. · The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 25339295
  • The Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · The Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · The Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Epidemiology, University of Maastricht, Maastricht, The Netherlands. · Pubmed 25241047
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25827470
2014
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium Research and Development Group VitaK, Maastricht University, Maastricht, The Netherlands · Pubmed 25246482
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan; · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique and Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, Netherlands. · Pubmed 25122867
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands. · Pubmed 25090617
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium Nephrology Department, Grand Hôpital de Charleroi, Gilly, Belgium. · Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24876198
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; · Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; Nephrology Department, Grand Hôpital de Charleroi, Gilly Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven Belgium; · Division of Nephrology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven Belgium; Department of Epidemiology, Maastricht University, Maastricht The Netherlands. · Pubmed 24795400
  • Institute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Lausanne, Switzerland. · Service of Nephrology, University Hospital of Lausanne, Lausanne, Switzerland. · Service of Nephrology, Department of Specialties, University Hospital of Geneva, Geneva, Switzerland. · Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland. · Institute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Lausanne, Switzerland; Unit of Population Epidemiology, University Hospital of Geneva, Geneva, Switzerland. · Department of Cardiology, University Hospital of Geneva, Geneva, Switzerland. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Community Medicine and Primary Care and Emergency Medicine, University Hospital of Geneva, Geneva, Switzerland. · Pubmed 24663506
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Department of Internal Medicine, Division of Hypertension, University Medical Centre Ljubljana, Slovenia. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Steno Diabetes Center, Gentofte and Research Centre for Prevention and Health, Gentofte, Denmark. · Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark. · Copenhagen University Hospital, Copenhagen, Denmark. · Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom. · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland. · Department of Medicine, University of Padua, Padua, Italy. · Institute of Internal Medicine, Novosibirsk, Russian Federation. · Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. · Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay. · Faculty of Medicine, Charles University, Pilsen, Czech Republic. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Center for Epidemiological Studies and Clinical Trials and. · Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Department of Epidemiology, Maastricht University, Maastricht, Netherlands · Pubmed 24572704
  • Steno Diabetes Centre, Gentofte and Research Centre for Prevention and Health, Glostrup, Denmark. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · 1] Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiantong University School of Medicine, Shanghai, China [2] Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiantong University School of Medicine, Shanghai, China. · Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · 1] Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. · Department of Health Sciences, Shiga University of Medical Sciences, Otsu, Japan. · Copenhagen University Hospital, Copenhagen, Denmark. · Addenbrook's Hospital, Cambridge University Hospitals, Cambridge, UK. · First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Kra-ków, Poland. · Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy. · Institute of Internal Medicine, Novosibirsk, Russian Federation. · The Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay. · Faculty of Medicine, Charles University, Pilsen, Czech Republic. · Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiantong University School of Medicine, Shanghai, China. · The Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · 1] Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] The Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24430701
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium. · Department of Pharmacology, Maastricht University, Maastricht, The Netherlands. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24152823
  • 1] Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium [2] Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Faculté de Médecine, Université Paris Descartes, Paris, France. · Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands. · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · Third Department of Internal Medicine, General Faculty Hospital, Prague, Czech Republic. · Department of Cardiology, Ullevål University Hospital, University of Oslo, Oslo, Norway. · BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. · Hypertension Unit, Geneva University Hospital, Geneva, Switzerland. · Service of Nephrology, Lausanne University Hospital, Lausanne, Switzerland. · Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24067345
  • Studies Coordinating Center, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pole of the Cardiovascular Research, Institut de Recherche Expérimentale et Clinique and Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 24842938
2011
  • The Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Research, University of Leuven, Leuven, Belgium. · Pubmed 21235787
2010
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, Block d, Level 00, Box 7001, B-3000 Leuven, Belgium. · Pubmed 20212274
2008
  • Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, University Hospital Maastricht, Maastricht, The Netherlands. · Pubmed 19020427
  • Department of Cardiovascular Diseases, Division of Hypertension and Cardiovascular Rehabilitation, Studies Coordinating Centre, University of Leuven, Leuven, Belgium. · Pubmed 18496288
2007
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17556887
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17283254
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Campus Gasthuisberg, University of Leuven, B 3000 Leuven, Belgium. · Pubmed 17467493
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17760215
2017
  • aDepartment of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Bern, Switzerland bMount Sinai Icahn School of Medicine, New York, New York, USA cJagiellonian University Krakow, Kraków, Poland dDepartment of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Brescia, Italy eService de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland fDepartment of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, Washington gHeart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine, California, USA hDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland iDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan jDepartment of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway kCardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA lDepartment of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, Paris, France mHypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, Canada nDepartment of Heart Diseases, University of Bergen, Haukeland Hospital, Bergen, Norway oUniversity of Milano-Bicocca pIRCCS Istituto Auxologico Italiano, Milan, Italy qDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland rHypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington, District of Columbia, USA sDepartment of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano tDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy uImperial Clinical Trials Unit, Imperial College London, London, UK vHospital Clinico Unviersitario de Valencia, Valencia wDepartment of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain xDepartment of Medicine, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Québec, Canada yDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany zDivision of Nephrology and Hypertension, Department of Medicine aaAmerican Society of Hypertension, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA bbInternational Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London - Hammersmith Campus, London, UK ccDiabetes and Cardiovascular Center, University of Missouri School of Medicine ddDepartment Service, Harry S Truman Memorial Veterans Hospital eeDepartment of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri, USA ffUniversity of Leuven, Leuven, Belgium ggDepartment of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China hhSUNY Downstate Medical Center, Brooklyn, New York, USA iiUniversity College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, London, UK jjDepartment of Medicine, Masstricht University Medical Center, Maastricht University, Maastricht, the Netherlands. · Pubmed 28657972
  • Departments of Pediatrics and Neonatology (A.R., E.L.) and Laboratory Medicine (J.C., S.P.), University Hospitals Leuven, Belgium; KU Leuven Department of Development and Regeneration (A.R., E.L., K.A.) and Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (Z.-Y.Z., N.C., F.-F.W., L.J., T.K., J.A.S.), University of Leuven, Belgium; Department of Sociology, Vrije Universiteit Brussel, Belgium (T.P. v.T.); R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.); and Intensive Care and Department of Pediatric Surgery, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands (K.A.). · Departments of Pediatrics and Neonatology (A.R., E.L.) and Laboratory Medicine (J.C., S.P.), University Hospitals Leuven, Belgium; KU Leuven Department of Development and Regeneration (A.R., E.L., K.A.) and Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (Z.-Y.Z., N.C., F.-F.W., L.J., T.K., J.A.S.), University of Leuven, Belgium; Department of Sociology, Vrije Universiteit Brussel, Belgium (T.P. v.T.); R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.); and Intensive Care and Department of Pediatric Surgery, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands (K.A.). · Pubmed 28115515
  • From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L.); Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine (S.S.F.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland (E.O.); and R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L.); Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine (S.S.F.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland (E.O.); and R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · Pubmed 28847889
  • From the Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (J.M., G.E.M.); Department of Biomedical Sciences, University of Texas Rio Grande Valley School of Medicine, Brownsville (G.E.M.); Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.A., Y.I.); Studies Coordinating Centre, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Department of Medicine, University of Padua, Italy (E.C.); the Steno Diabetes Center Copenhagen, Gentofte and RCPH, Centre for Health, Capital Region of Denmark, Denmark (T.W.H.); KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.J., T.K., L.T., J.A.S.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Denmark (J.J.); The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.K.J., K.S.S.); Research Unit Hypertension and Cardiovascular Epidemiology, Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., J.-G.W.); Institute of Internal and Preventive Medicine, Novosibirsk, Russia (T.K., S.M., Y.N.); and R & D Group VitaK, Maastricht University, The Netherlands (JAS). · From the Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (J.M., G.E.M.); Department of Biomedical Sciences, University of Texas Rio Grande Valley School of Medicine, Brownsville (G.E.M.); Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.A., Y.I.); Studies Coordinating Centre, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Department of Medicine, University of Padua, Italy (E.C.); the Steno Diabetes Center Copenhagen, Gentofte and RCPH, Centre for Health, Capital Region of Denmark, Denmark (T.W.H.); KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.J., T.K., L.T., J.A.S.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Denmark (J.J.); The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.K.J., K.S.S.); Research Unit Hypertension and Cardiovascular Epidemiology, Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., J.-G.W.); Institute of Internal and Preventive Medicine, Novosibirsk, Russia (T.K., S.M., Y.N.); and R & D Group VitaK, Maastricht University, The Netherlands (JAS). · Pubmed 28483916
  • aDivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical CentrebCAPHRI School for Public Health and Primary CarecDepartment of Epidemiology, Maastricht UniversitydDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The NetherlandseResearch Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, Studies Coordinating Centre, University of Leuven, Leuven, BelgiumfDepartment of Internal Medicine, Maasticht University Medical CentergCARIM School for Cardiovascular Diseases, Maastricht University Medical CentrehCARIM School for Cardiovascular Diseases, and MaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, The Netherlands. · Pubmed 28355168
2016
  • From the Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (A.P., E.B.); Department of Medical Sciences, Internal Medicine and Hypertension Division, AOU Città della Salute e della Scienza, Turin, Italy (F.R., E.B.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.); Paris-Descartes University, F-75005 Paris, France (M.A.); Assistance Publique-Hôpitaux de Paris, Hypertension Unit, Hôpital Européen Georges Pompidou, F-75015 Paris, France (M.A.); Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigations Cliniques 1418, F-75015 Paris, France (M.A.); Department of Cardiology (S.E.K.) and Department of Nephrology (A.H.), Ullevaal University Hospital, University of Oslo, Oslo, Norway; and Clinical Chemistry Department, Cliniques Universitaires St Luc, Brussels, Belgium; Louvain Center for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium (P.W, A.C.). · From the Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (A.P., E.B.); Department of Medical Sciences, Internal Medicine and Hypertension Division, AOU Città della Salute e della Scienza, Turin, Italy (F.R., E.B.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.); Paris-Descartes University, F-75005 Paris, France (M.A.); Assistance Publique-Hôpitaux de Paris, Hypertension Unit, Hôpital Européen Georges Pompidou, F-75015 Paris, France (M.A.); Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigations Cliniques 1418, F-75015 Paris, France (M.A.); Department of Cardiology (S.E.K.) and Department of Nephrology (A.H.), Ullevaal University Hospital, University of Oslo, Oslo, Norway; and Clinical Chemistry Department, Cliniques Universitaires St Luc, Brussels, Belgium; Louvain Center for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium (P.W, A.C.). · Pubmed 27296995
  • From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.). · From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.). · Pubmed 26711735
  • aDivision of Rheumatology, Department of Internal Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre+, Maastricht, The Netherlands bStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium cFirst Department of Cardiology and Hypertension, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland dInstitute of Internal and Preventive Medicine, Novosibirsk, Russian Federation eDepartment of Clinical and Experimental Medicine, University of Padova, Padova fDepartment of Health Sciences, University of Milan, Milan, Italy gFaculty of Medicine, Charles University, Pilsen, Czech Republic hSchool of Nephrology, Vita-Salute San Raffaele University iInstitute of Biomedical Technologies, Italian National Centre of Research, Milan, Italy jVitaK R & D Group kDepartment of Epidemiology, CAPHRI School for Public Health and Primary Care, CARIM School for Cardiovascular Sciences, and MaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, The Netherlands. · Pubmed 27607461
  • From the Departments of Cardiology, Internal Medicine, and Radiology, Isala Hospital, Zwolle, The Netherlands (M.R.d.J., A.A., P.G., J.J.J.S., P.P.H.M.D., J.-E.H., B.A.A.M.v.H., A.R.R.M., A.E.); Center for Innovation and Strategic Collaboration, St Jude Medical, Inc, Irvine, CA (E.O.Y.L.); Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (A.P.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.); The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S.); and University of Rochester School of Medicine & Dentistry, Arrhythmia Institute of The Valley Health System, New York and Ridgewood, NJ (J.S.S.). · From the Departments of Cardiology, Internal Medicine, and Radiology, Isala Hospital, Zwolle, The Netherlands (M.R.d.J., A.A., P.G., J.J.J.S., P.P.H.M.D., J.-E.H., B.A.A.M.v.H., A.R.R.M., A.E.); Center for Innovation and Strategic Collaboration, St Jude Medical, Inc, Irvine, CA (E.O.Y.L.); Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (A.P.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.); The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S.); and University of Rochester School of Medicine & Dentistry, Arrhythmia Institute of The Valley Health System, New York and Ridgewood, NJ (J.S.S.). · Pubmed 27432864
  • From the Departments of Cardiology, Internal Medicine and Radiology, Isala Hospital, Zwolle, The Netherlands (M.R.d.J., A.F.H., P.G., A.A., J.J.J.S., P.P.H.M.D., A.R.R.M., B.A.A.M.v.H., J.-E.H., A.E.); Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc., Irvine, CA (E.O.Y.L.); The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Departments of Cardiology, Internal Medicine and Radiology, Isala Hospital, Zwolle, The Netherlands (M.R.d.J., A.F.H., P.G., A.A., J.J.J.S., P.P.H.M.D., A.R.R.M., B.A.A.M.v.H., J.-E.H., A.E.); Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc., Irvine, CA (E.O.Y.L.); The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 27113046
  • From the Pole of Cardiovascular Research (AP, LE, SH), Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium; Cardiology Department (AP, GN), Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; Human Molecular Genetics (LE, AM, MV), de Duve Institute, Université catholique de Louvain, Brussels, Belgium; Studies Coordinating Centre (YJ, W-YY, JAS), Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Population Health and Optimal Health Practices Research Unit (GN), CHU de Québec Research Centre, Québec, Canada; Pôle de recherche en Endocrinologie (DG), Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; Department of Laboratory Medicine (DG), Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; and Research and Development VitaK Group (JAS), Maastricht University, Maastricht, The Netherlands. · Pubmed 27082544
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.N.O., L.T., A.H., F.-F.W., L.J., J.A.S.); Department of Internal Medicine, Faculty of Clinical Sciences (A.N.O.), Department of Human Physiology (J.O.O.), and Department of Chemical Pathology (M.M.N.), Faculty of Basic Clinical Sciences, College of Health Sciences, University of Abuja, Abuja, Nigeria; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina (L.S.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Department of Health, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., T.O., Y.I.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B., L.L.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O.); and R & D Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.N.O., L.T., A.H., F.-F.W., L.J., J.A.S.); Department of Internal Medicine, Faculty of Clinical Sciences (A.N.O.), Department of Human Physiology (J.O.O.), and Department of Chemical Pathology (M.M.N.), Faculty of Basic Clinical Sciences, College of Health Sciences, University of Abuja, Abuja, Nigeria; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina (L.S.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Department of Health, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., T.O., Y.I.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B., L.L.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O.); and R & D Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 27067719
2015
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (F.-F.W., A.H., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); the Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Copenhagen, Denmark (T.W.H.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (F.-F.W., A.H., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); the Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Copenhagen, Denmark (T.W.H.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25916728
  • From the Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine (S.S.F.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O'B.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Maastricht University, Maastricht, The Netherlands (J.A.S.); and Vitak Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine (S.S.F.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O'B.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Maastricht University, Maastricht, The Netherlands (J.A.S.); and Vitak Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25287401
  • From the Division of Hypertension, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Capital Federal, Argentina (L.S.A., Jessica Barochiner, J.A., P.E.C., G.D.W.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., L.J., A.N.O., J.A.S.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (José Boggia); Department of Internal Medicine, College of Health Sciences, University of Abuja, Abuja, Nigeria (A.N.O.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., K.N., T.O.); Department of Public Health, Tohoku University Graduate School of Medicine, Sendai, Japan (I.T.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (M.K., Y.I.); and R & D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Division of Hypertension, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Capital Federal, Argentina (L.S.A., Jessica Barochiner, J.A., P.E.C., G.D.W.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., L.J., A.N.O., J.A.S.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (José Boggia); Department of Internal Medicine, College of Health Sciences, University of Abuja, Abuja, Nigeria (A.N.O.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., K.N., T.O.); Department of Public Health, Tohoku University Graduate School of Medicine, Sendai, Japan (I.T.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (M.K., Y.I.); and R & D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 26355122
  • aDepartment of Vascular Medicine, Radboud University Medical Centre, Nijmegen bDepartment of Cardiology, Isala Hospital, Zwolle, the Netherlands cDepartment of Cardiovascular Sciences, Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, University of Leuven, Belgium. · Pubmed 26259118
  • aInstitute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Lausanne bDepartment of Cardiology cService of Nephrology, Department of Specialties, University Hospital of Geneva, Geneva dService of Nephrology, University Hospital of Lausanne, Lausanne eDepartment of Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Bern fUnit of Population Epidemiology, University Hospital of Geneva, Geneva, Switzerland gStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium hDepartment of Epidemiology, Maastricht University, Maastricht, the Netherlands iDepartment of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Japan jSwiss Institute of Bioinformatics, University of Lausanne, Lausanne kDepartment of Community Medicine and Primary Care and Emergency Medicine, University Hospital of Geneva, Geneva, Switzerland. · Pubmed 26203966
  • aResearch Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, Studies Coordinating Centre, University of Leuven, Leuven, Belgium bDepartment of Internal Medicine, Division of Cardiology, College of Health Sciences, University of Abuja cDepartment of Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria dTohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan eDepartment of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 26154854
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven , Belgium. · Pubmed 25541647
  • From the Unit of Population Epidemiology, Department of Community Medicine and Primary Care and Emergency Medicine (I.G.), Service of Nephrology, Department of Specialties (B.P., P.-Y.M.), Department of Cardiology (G.E.), and Unit of Hypertension, Department of Community Medicine and Primary Care and Emergency Medicine (I.G., A.P.-B.), University Hospital of Geneva, Switzerland; Institute of Social and Preventive Medicine (IUMSP) (I.G., B.P., G.E., P.V., F.P., M.B.), and Department of Medicine, Service of Nephrology (M.P., M.B.), University Hospital of Lausanne, Switzerland; Department of Nephrology and Hypertension, Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Switzerland (D.A., M.M., B.V.); Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neurosciences, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Hospital of Cery, Prilly, Switzerland (N.A., C.B.E.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University Leuven, Belgium (J.S., Y.G.); Department of Epidemiology, Maastricht University, Maastricht, Netherlands (J.S.); and Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland (C.B.E.). · From the Unit of Population Epidemiology, Department of Community Medicine and Primary Care and Emergency Medicine (I.G.), Service of Nephrology, Department of Specialties (B.P., P.-Y.M.), Department of Cardiology (G.E.), and Unit of Hypertension, Department of Community Medicine and Primary Care and Emergency Medicine (I.G., A.P.-B.), University Hospital of Geneva, Switzerland; Institute of Social and Preventive Medicine (IUMSP) (I.G., B.P., G.E., P.V., F.P., M.B.), and Department of Medicine, Service of Nephrology (M.P., M.B.), University Hospital of Lausanne, Switzerland; Department of Nephrology and Hypertension, Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Switzerland (D.A., M.M., B.V.); Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neurosciences, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Hospital of Cery, Prilly, Switzerland (N.A., C.B.E.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University Leuven, Belgium (J.S., Y.G.); Department of Epidemiology, Maastricht University, Maastricht, Netherlands (J.S.); and Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland (C.B.E.). · Pubmed 25489060
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.H., L.T., Y.-M.G., L.J., Z.-Y.Z., Y.-P.L., J.A.S.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Centre for Environmental Sciences, University of Hasselt, Hasselt, Belgium (T.S.N.); and Research and Development Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.H., L.T., Y.-M.G., L.J., Z.-Y.Z., Y.-P.L., J.A.S.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Centre for Environmental Sciences, University of Hasselt, Hasselt, Belgium (T.S.N.); and Research and Development Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25287397
2014
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Pubmed 23573998
  • From the Institute of Cardiovascular & Medical Sciences (E.M.F.) and School of Medicine (C.G.P., P.O.D.), University of Glasgow, Glasgow, United Kingdom; Studies Coordinating Center, Research Unit Hypertension and Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Director's Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (G.L.J.); Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson (J.P.G.); Department of Cardiology, Ghent University, Ghent, Belgium (M.D.B.); and Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Province of Quebec, Canada (E.L.S.). · From the Institute of Cardiovascular & Medical Sciences (E.M.F.) and School of Medicine (C.G.P., P.O.D.), University of Glasgow, Glasgow, United Kingdom; Studies Coordinating Center, Research Unit Hypertension and Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Director's Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (G.L.J.); Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson (J.P.G.); Department of Cardiology, Ghent University, Ghent, Belgium (M.D.B.); and Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Province of Quebec, Canada (E.L.S.). · Pubmed 25156173
  • aPole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain bDivision of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium cAssistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou and Université Paris Descartes, Paris, France dStudies Coordinating Center, Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, Leuven, Belgium eDepartment of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden fThird Department of Internal Medicine, General Faculty Hospital, Prague, Czech Republic gDepartment of Cardiology, Ullevaal University Hospital, University of Oslo, Oslo, Norway hDepartment of Cardiology, Geneva University Hospitals, Geneva iDepartment of Nephrology, Lausanne University Hospital, Lausanne, Switzerland jBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom kDepartment of Cardiology, Isala Klinieken, Zwolle, the Netherlands lKarolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden mDepartment of Epidemiology, Maastricht University, Maastricht, the Netherlands. · Pubmed 25375391
  • From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK (P.B.M., A.F.D.); Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, PQ, Canada (E.L.S.); Director's Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (G.L.J.); Center for Epidemiological Studies and Clinical Trials, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai, China (J.-G.W.); Department of Cardiology, Ghent University, Ghent, Belgium (M.D.B.); and Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK (P.B.M., A.F.D.); Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, PQ, Canada (E.L.S.); Director's Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (G.L.J.); Center for Epidemiological Studies and Clinical Trials, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai, China (J.-G.W.); Department of Cardiology, Ghent University, Ghent, Belgium (M.D.B.); and Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25245390
  • From the Cardiovascular Research Institut Basel and Department of Medicine, University Hospital Basel, Basel, Switzerland (D.C., S.A., T.S.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., Y.-M.G., T.K., J.A.S.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L., J.-G.W.); Centro de Nefrologìa and Departamento de Fisiopatologìa, Hospital de Clìnicas, Universidad de la Repûblica, Montevideo, Uruguay (J.B.); Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Gentofte, Denmark (T.W.H.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., M.K., T.O., Y.I.); Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden (K.B.-B.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark (J.J.); Department of Health, Science and Technology, Aalborg University, Aalborg, Denmark (C.T.-P.); Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom (E.D.); First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakòw, Poland (K.S.-S., K.K.-J.); Department of Medicine, University of Padova, Padova, Italy (V.T., E.C.); Institute of Internal Medicine, Novosibirsk, Russian Federation (S.M., Y.N.); Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (L.L.); Asoci · Pubmed 25185130
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (K.A., L.T., Y.-M.G., A.H., Y.-P.L., Z.Z., F.-F.W., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., T.O., Y.I.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L., F.-F.W., J.W.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (I.L., J.B., L. Luzardo); Departamento de Informática, Universidad Politécnica de Sinaloa, Mazatlán, Mexico (L.J.M.); Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Denmark (T.W.H.); Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (K.B.-B., L. Lind); Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden (K.B.-B.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.N., T.O.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark (J.J.); Department of Health Science and Technology, Aalborg University, Aalborg, Denmark (C.T.-P.); Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom (E.D.); First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S.-S., K.K.-J.); Department of Medicine, University of Padua, Padua, Italy (E.C.); Institute of Internal Medicine, Novosibirsk, Russian Federation (S.M., Y.N.); Faculty of Medicine, Charles University, Pilsen, Czec · Pubmed 25135185
  • From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.N., K.A., T.O.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (K.A., L.T., A. Hara, J.A.S.); Graduate School of Pharmaceutical Sciences (K.A., Y.I.), Tohoku Medical Megabank Organization (A. Hozawa), and Graduate School of Medicine (I.T.), Tohoku University, Sendai, Japan; Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Medicine, Turku University Hospital, Turku, Finland (T.J.N.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (I.L., J.B.); the Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (A.K., G.S.S.); and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.N., K.A., T.O.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (K.A., L.T., A. Hara, J.A.S.); Graduate School of Pharmaceutical Sciences (K.A., Y.I.), Tohoku Medical Megabank Organization (A. Hozawa), and Graduate School of Medicine (I.T.), Tohoku University, Sendai, Japan; Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Medicine, Turku University Hospital, Turku, Finland (T.J.N.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (I.L., J.B.); the Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (A.K., G.S.S.); and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 24980664
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L., F.-F.W., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., Y.-M.G., Y.-P.L., T.K., J.A.S.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Tohoku University Graduate School of Pharmaceutical Sciences and Medicine, Sendai, Japan (K.A., M.K., T.O., Y.I.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Research Center for Prevention and Health and Steno Diabetes Center, Gentofte, Denmark (T.W.H.); Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden (K.B.-B.); Department of Medicine, Glostrup Hopsital, University of Copenhagen, Copenhagen, Denmark (J.J.); Copenhagen University Hospital, Copenhagen, Denmark (C.-T.P.); Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom (E.D.); First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland (K.S.-S., K.K.-J.); Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy (V.T., E.C.); Institute of Internal Medicine, Novosibirsk, Russian Federation (S.M., Y.N.); Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (L.L.); Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.); Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (L.M., G.E.M.); Faculty · Pubmed 24906822
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven , Leuven , Belgium. · Pubmed 24742341
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Kapucijnenvoer 35, Box 7001, BE-3000 Leuven, Belgium. · Pubmed 24664290
  • Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 24662447
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, block D, Box 7001, BE-3000 Leuven, Belgium. or · Pubmed 24535008
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, Block D, Box 7001, BE-3000 Leuven, Belgium. or · Pubmed 24420553
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven, Kapucijnenvoer 35, Block D, Box 7001, BE-3000 Leuven, Belgium. · Pubmed 24324050
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven , Belgium. · Pubmed 24066715
2013
  • Studies Coordinating Centre, Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 23892701
  • Department of Geriatric Medicine & Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan and Department of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan and Research Institute, National Cerebro & Cardiovascular Research Center, Osaka, Japan and Studies Coordinating Centre, Research Unit Hypertension & Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 24192120
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, Block D, Box 7001, B-3000 Leuven, Belgium. · Pubmed 24060898
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, Campus Sint Rafaël, Kapucijnenvoer 35, Block D, Box 7001, BE-3000 Leuven, Belgium. · Pubmed 24019403
  • 1] Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Hypertension Unit, Department of Internal Medicine, University of Kinshasa Hospital, Kinshasa, Democratic Republic of Congo. · Pubmed 23803591
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Belgium. · Pubmed 23382332
  • Studies Coordinating Center, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 23172933
2012
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Pubmed 22810950
  • 1] Department of Cardiovascular Diseases, Division of Hypertension and Cardiovascular Rehabilitation, Studies Coordinating Centre, University of Leuven, Leuven, Belgium [2] Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Pubmed 22895063
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, B 3000 Leuven, Belgium. · Pubmed 22789915
  • The Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, University of Leuven, Leuven, Belgium. · Pubmed 22622108
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven Campus Sint Rafaël, Kapucijnenvoer 35, Block D, Box 7001, Leuven BE-3000, Belgium. · Pubmed 22594907
2011
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 21850060
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 21540421
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 21495829
  • Studies Coordinating Centre, Laboratory of Hypertension, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 21228786
2010
  • Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 20613762
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Biomedical Sciences Group, University of Leuven, Leuven, Belgium. · Pubmed 20660518
  • Studies Coordinating Centre, Division of Hypertension and Cardiac Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 20404600
  • Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Studies Coordinating Centre, Leuven, Belgium. · Pubmed 20051905
2009
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 19747655
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Campus Gasthuisberg, Herestraat 49, Leuven, Belgium. · Pubmed 19581508
  • Hypertension and Cardiovascular Rehabilitation Unit, Faculty of Medicine, University of Leuven, Leuven, Belgium. · Pubmed 19225527
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 18787518
2008
  • Department ofCardiovascular Diseases, Division of Hypertension and Cardiovascular Rehabilitation, Studies Coordinating Centre, University of Leuven, Leuven, Belgium. · Pubmed 19001188
  • Hypertension and Cardiovascular Rehabilitation Unit, Faculty of Medicine, University of Leuven, KU Leuven, Belgium. · Pubmed 18756173
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 18551007
  • Department of Cardiovascular Diseases, Division of Hypertension and Cardiovascular Rehabilitation, Studies Coordinating Centre, University of Leuven, Leuven, Belgium. · Pubmed 18496289
  • The Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 18327082
  • Hypertension and Cardiovascular Rehabilitation Unit, Faculty of Medicine, University of Leuven, Belgium. · Pubmed 18039980
2007
  • Studies Coordinating Center, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17765144
  • Hypertension and Cardiovascular Rehabilitation Unit, University of Leuven K.U. Leuven, Leuven, Belgium. · Pubmed 17921823
  • Hypertension and Cardiovascular Rehabilitation Unit, University of Leuven, B-3000 Leuven, Belgium. · Pubmed 17893310
  • Studies Coordinating Centre, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17760218
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17547477
  • Studies Coordinating Centre, Division of Hypertension and Cardiovascular Research, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Pubmed 17452507
  • Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Studies Coordinating Centre, University of Leuven, Leuven, Belgium. · Pubmed 17301826
  • Studies Coordinating Centre, Laboratory of Hypertension, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Campus Gasthuisberg, University of Leuven, Leuven, Belgium. · Pubmed 17242009
Maastricht University
2017
  • Division of Nephrology and Hypertension, Department of Medicine, University of California, San Diego, La Jolla. · Imperial Valley Family Care Medical Group, El Centro, California. · Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, Canada. · Department of Biostatistics and Bioinformatics, MedStar Health Research Institute, Hyattsville, Maryland. · Georgetown-Howard Universities Center for Clinical and Translational Research, Hyattsville, Maryland. · Department of Public Health and Primary Care, University of Cambridge, Cambridge, England. · School of Biological and Population Health Sciences, Oregon State University, Corvallis. · Division of Nephrology, Department of Medicine, University of California, San Francisco. · Division of Nephrology and Hypertension, Department of Internal Medicine, University of Utah, Salt Lake City. · Medical Service, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah. · Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. · Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, England. · Istituto Auxologico Italiano, Center of Clinical Physiology and Hypertension, Università Degli Studi di Milano, Milan, Italy. · School of Public Health, Imperial College London, London, England. · Care of the Elderly, Imperial College London, London, England. · Research Unit Hypertension and Cardiovascular Epidemiology, Katholieke Universiteit Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Research and Development Group VitaK, Maastricht University, Maastricht, the Netherlands. · Division of Preventive Medicine, Department of Family Medicine and Public Health, University of California, San Diego, La Jolla. · Nephrology Section, Veterans Affairs San Diego Healthcare System, La Jolla, California. · Pubmed 28873137
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · R&D Group VitaK, Maastricht University, Maastricht, The Netherlands. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Department of Social Pharmacy and Public Health, Showa Pharmaceutical University, Tokyo, Japan. · Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Eamon Dolan, Stroke and Hypertension Unit, Connolly Hospital, Blanchardstown, Co, Dublin, Ireland. · Conway Institute, University College Dublin, Dublin, Ireland. · Pubmed 28052877
  • Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences (Offices C340A-B), University of California, Irvine, CA 92697-4079, USA. · Conway Institute of Bimolecular and Biomedical Research, University College, Dublin, Dublin, Ireland. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiological KLI Leuven, Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 27836914
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (C.-S.S., Y.-B.C., Q.-H.G., F.-K.L., Q.-F.H., J.-G.W., Y.L.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (F.-F.W., W.-Y.Y., L.T., J.A.S.); and R & D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (C.-S.S., Y.-B.C., Q.-H.G., F.-K.L., Q.-F.H., J.-G.W., Y.L.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (F.-F.W., W.-Y.Y., L.T., J.A.S.); and R & D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · Pubmed 27821618
2016
  • Università Vita Salute San Raffaele, Chair of Nephrology; IRCCS San Raffaele Scientific Institute, Genomics of Renal Disease and Hypertension Unit, Via Olgettina 60, 20132, Milan, Italy. · CVie Therapeutics Limited, Taipei, Taiwan. · Italian National Centre of Research, Institute of Biomedical Technologies, Segrate, Milan, Italy. · Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · R&D Group VitaK, Maastricht University, Maastricht, The Netherlands. · Università Vita Salute San Raffaele, Chair of Nephrology; IRCCS San Raffaele Scientific Institute, Genomics of Renal Disease and Hypertension Unit, Via Olgettina 60, 20132, Milan, Italy. · CVie Therapeutics Limited, Taipei, Taiwan. · Pubmed 26915067
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Cardiology, Ullevaal University Hospital, University of Oslo, Oslo, Norway. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · R & D VitaK Group, Maastricht University, Maastricht, The Netherlands. · Paris-Descartes University, F-75005, Paris, France. · Assistance Publique-Hôpitaux de Paris, Hypertension Unit, Hôpital Européen Georges Pompidou, F-75015, Paris, France. · Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigations Cliniques 1418, F-75015, Paris, France. · Pubmed 26739586
  • Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine, Irvine, California. Electronic address: · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Gentofte, Denmark. · Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden; Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark. · Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom. · Institute of Internal Medicine, Novosibirsk, Russian Federation. · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland. · Department of Medicine, University of Padua, Padua, Italy. · Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay. · Faculty of Medicine, Charles University, Pilsen, Czech Republic. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands. · Pubmed 27810041
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Department of Development and Regeneration, University of Leuven, Leuven, Belgium. · Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Department of Pharmacology, Maastricht University, Maastricht, The Netherlands. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · R & D Group VitaK, Maastricht University, Maastricht, The Netherlands. · Pubmed 27383509
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (F.-F.W., Z.-Y.Z, L.T., W.-Y.Y, L.J., N.C., Y.-M.G., T.K., J.A.S.), Department of Development and Regeneration (K.A.), Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences (P.V.), University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and R&D Group VitaK (J.A.S.), Maastricht University, Maastricht, The Netherlands. · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (F.-F.W., Z.-Y.Z, L.T., W.-Y.Y, L.J., N.C., Y.-M.G., T.K., J.A.S.), Department of Development and Regeneration (K.A.), Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences (P.V.), University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and R&D Group VitaK (J.A.S.), Maastricht University, Maastricht, The Netherlands. · Pubmed 27324224
  • Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan Japan Development and Medical Affairs, GlaxoSmithKline KK, Tokyo, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan. · Embassy of Japan, Rome, Italy. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium R&D VitaK Group, Maastricht University, Maastricht, The Netherlands. · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan · Pubmed 27009620
  • a Department of Cardiology, The First Affiliated Hospital , Nanjing Medical University , Nanjing , PR China ; · b Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences , University of Leuven , Leuven , Belgium ; · c Department of Internal Medicine, College of Health Sciences , University of Abuja , Abuja , Nigeria ; · d The Health Bureau of Gaoyou , Gaoyou , PR China ; · e R&D VitaK Group , Maastricht University , Maastricht , The Netherlands. · Pubmed 26581308
  • Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; · Department of Cardiology, Shandong Provincial Hospital of Traditional Chinese Medicine, Jinan, Shandong, China; · Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; R & D VitaK Group, Maastricht University, Maastricht, The Netherlands. · Pubmed 26150543
2015
  • First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. Electronic address: · Pubmed 25704347
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. Electronic address: · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Department of General Internal Medicine, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway; Department of Cardiology, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway. · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Nephrology, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway. · Department of Cardiology, Ullevaal University Hospital, University of Oslo, Faculty of Medicine, Oslo, Norway. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25601357
  • 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25319600
  • Department of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 26506526
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Z.-Y.Z., L.T., T.P., Y.-M.G., L.J., W.-Y.Y., Y.-P.L., Y.J., T. Kuznetsova, J.A.S.), Centre for Molecular and Vascular Biology (P.V.), and Research Unit Cardiology (J.-U.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Mosaiques Diagnostic and Therapeutics GmbH, Hannover, Germany (T. Koeck, P.Z., H.M.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom (H.M.); and R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 26063667
  • Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Hygiene and Public health, Teikyo University School of Medicine, Tokyo, Japan. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Department of Environmental Health Sciences, Tohoku University Graduate School of Medicine, Sendai, Japan. · Department of Development and Environmental Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. · Department of Pharmacy, Tohoku University Hospital, Sendai, Japan. · Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan. · Professor Emeritus, Tohoku University, Sendai, Japan. · Pubmed 25971628
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (L.Z., Y.L., F.-F.W., Y.-Y.K., S.W., T.-Y.X., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (L.Z., Y.L., F.-F.W., Y.-Y.K., S.W., T.-Y.X., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25870194
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Y.-M.G., Y.-P.L., L.T., T.P., Z.Z., T.K., J.A.S.) and Center for Molecular and Vascular Biology (P.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (S.W., L.Z., F.-F.W., Y.-Y.K., Q.-F.H.,C.-S.S.,Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and VitaK Research and Development (J.A.S.), Maastricht University, Maastricht, The Netherlands. · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Y.-M.G., Y.-P.L., L.T., T.P., Z.Z., T.K., J.A.S.) and Center for Molecular and Vascular Biology (P.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (S.W., L.Z., F.-F.W., Y.-Y.K., Q.-F.H.,C.-S.S.,Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and VitaK Research and Development (J.A.S.), Maastricht University, Maastricht, The Netherlands. · Pubmed 25712718
  • Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland; Department of Medicine, Turku University Hospital, Turku, Finland; · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland; · Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan; · Department of Public Health, Tohoku University Graduate School of Medicine, Sendai, Japan; · Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25399016
  • The Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · The Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · The Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Epidemiology, University of Maastricht, Maastricht, The Netherlands. · Pubmed 25241047
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; VitaK Research and Development, Maastricht University, Maastricht, The Netherlands. · Pubmed 25827470
2014
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium Research and Development Group VitaK, Maastricht University, Maastricht, The Netherlands · Pubmed 25246482
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan; · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique and Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, Netherlands. · Pubmed 25122867
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands. · Pubmed 25090617
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium Nephrology Department, Grand Hôpital de Charleroi, Gilly, Belgium. · Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24876198
  • Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; · Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; Nephrology Department, Grand Hôpital de Charleroi, Gilly Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven Belgium; · Division of Nephrology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven Belgium; Department of Epidemiology, Maastricht University, Maastricht The Netherlands. · Pubmed 24795400
  • Institute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Lausanne, Switzerland. · Service of Nephrology, University Hospital of Lausanne, Lausanne, Switzerland. · Service of Nephrology, Department of Specialties, University Hospital of Geneva, Geneva, Switzerland. · Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland. · Institute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Lausanne, Switzerland; Unit of Population Epidemiology, University Hospital of Geneva, Geneva, Switzerland. · Department of Cardiology, University Hospital of Geneva, Geneva, Switzerland. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Department of Community Medicine and Primary Care and Emergency Medicine, University Hospital of Geneva, Geneva, Switzerland. · Pubmed 24663506
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Department of Internal Medicine, Division of Hypertension, University Medical Centre Ljubljana, Slovenia. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium. · Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Steno Diabetes Center, Gentofte and Research Centre for Prevention and Health, Gentofte, Denmark. · Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan. · Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark. · Copenhagen University Hospital, Copenhagen, Denmark. · Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom. · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland. · Department of Medicine, University of Padua, Padua, Italy. · Institute of Internal Medicine, Novosibirsk, Russian Federation. · Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. · Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay. · Faculty of Medicine, Charles University, Pilsen, Czech Republic. · Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Center for Epidemiological Studies and Clinical Trials and. · Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium Department of Epidemiology, Maastricht University, Maastricht, Netherlands · Pubmed 24572704
  • Steno Diabetes Centre, Gentofte and Research Centre for Prevention and Health, Glostrup, Denmark. · Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · 1] Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiantong University School of Medicine, Shanghai, China [2] Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiantong University School of Medicine, Shanghai, China. · Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · 1] Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan. · Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. · Department of Health Sciences, Shiga University of Medical Sciences, Otsu, Japan. · Copenhagen University Hospital, Copenhagen, Denmark. · Addenbrook's Hospital, Cambridge University Hospitals, Cambridge, UK. · First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Kra-ków, Poland. · Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy. · Institute of Internal Medicine, Novosibirsk, Russian Federation. · The Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay. · Faculty of Medicine, Charles University, Pilsen, Czech Republic. · Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiantong University School of Medicine, Shanghai, China. · The Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. · 1] Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] The Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24430701
  • Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan. · Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium. · Department of Pharmacology, Maastricht University, Maastricht, The Netherlands. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24152823
  • 1] Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium [2] Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. · Faculté de Médecine, Université Paris Descartes, Paris, France. · Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands. · Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · Third Department of Internal Medicine, General Faculty Hospital, Prague, Czech Republic. · Department of Cardiology, Ullevål University Hospital, University of Oslo, Oslo, Norway. · BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. · Hypertension Unit, Geneva University Hospital, Geneva, Switzerland. · Service of Nephrology, Lausanne University Hospital, Lausanne, Switzerland. · Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden. · 1] Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium [2] Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 24067345
2008
  • Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, University Hospital Maastricht, Maastricht, The Netherlands. · Pubmed 19020427
  • Genetic Epidemiology Unit, Department of Epidemiology, University of Maastricht, The Netherlands. · Pubmed 18413491
2017
  • aDepartment of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Bern, Switzerland bMount Sinai Icahn School of Medicine, New York, New York, USA cJagiellonian University Krakow, Kraków, Poland dDepartment of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Brescia, Italy eService de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland fDepartment of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, Washington gHeart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine, California, USA hDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland iDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan jDepartment of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway kCardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA lDepartment of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, Paris, France mHypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, Canada nDepartment of Heart Diseases, University of Bergen, Haukeland Hospital, Bergen, Norway oUniversity of Milano-Bicocca pIRCCS Istituto Auxologico Italiano, Milan, Italy qDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland rHypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington, District of Columbia, USA sDepartment of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano tDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy uImperial Clinical Trials Unit, Imperial College London, London, UK vHospital Clinico Unviersitario de Valencia, Valencia wDepartment of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain xDepartment of Medicine, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Québec, Canada yDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany zDivision of Nephrology and Hypertension, Department of Medicine aaAmerican Society of Hypertension, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA bbInternational Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London - Hammersmith Campus, London, UK ccDiabetes and Cardiovascular Center, University of Missouri School of Medicine ddDepartment Service, Harry S Truman Memorial Veterans Hospital eeDepartment of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri, USA ffUniversity of Leuven, Leuven, Belgium ggDepartment of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China hhSUNY Downstate Medical Center, Brooklyn, New York, USA iiUniversity College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, London, UK jjDepartment of Medicine, Masstricht University Medical Center, Maastricht University, Maastricht, the Netherlands. · Pubmed 28657972
  • Departments of Pediatrics and Neonatology (A.R., E.L.) and Laboratory Medicine (J.C., S.P.), University Hospitals Leuven, Belgium; KU Leuven Department of Development and Regeneration (A.R., E.L., K.A.) and Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (Z.-Y.Z., N.C., F.-F.W., L.J., T.K., J.A.S.), University of Leuven, Belgium; Department of Sociology, Vrije Universiteit Brussel, Belgium (T.P. v.T.); R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.); and Intensive Care and Department of Pediatric Surgery, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands (K.A.). · Departments of Pediatrics and Neonatology (A.R., E.L.) and Laboratory Medicine (J.C., S.P.), University Hospitals Leuven, Belgium; KU Leuven Department of Development and Regeneration (A.R., E.L., K.A.) and Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (Z.-Y.Z., N.C., F.-F.W., L.J., T.K., J.A.S.), University of Leuven, Belgium; Department of Sociology, Vrije Universiteit Brussel, Belgium (T.P. v.T.); R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.); and Intensive Care and Department of Pediatric Surgery, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands (K.A.). · Pubmed 28115515
  • From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L.); Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine (S.S.F.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland (E.O.); and R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L.); Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine (S.S.F.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland (E.O.); and R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · Pubmed 28847889
  • From the Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (J.M., G.E.M.); Department of Biomedical Sciences, University of Texas Rio Grande Valley School of Medicine, Brownsville (G.E.M.); Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.A., Y.I.); Studies Coordinating Centre, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Department of Medicine, University of Padua, Italy (E.C.); the Steno Diabetes Center Copenhagen, Gentofte and RCPH, Centre for Health, Capital Region of Denmark, Denmark (T.W.H.); KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.J., T.K., L.T., J.A.S.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Denmark (J.J.); The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.K.J., K.S.S.); Research Unit Hypertension and Cardiovascular Epidemiology, Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., J.-G.W.); Institute of Internal and Preventive Medicine, Novosibirsk, Russia (T.K., S.M., Y.N.); and R & D Group VitaK, Maastricht University, The Netherlands (JAS). · From the Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (J.M., G.E.M.); Department of Biomedical Sciences, University of Texas Rio Grande Valley School of Medicine, Brownsville (G.E.M.); Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.A., Y.I.); Studies Coordinating Centre, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Department of Medicine, University of Padua, Italy (E.C.); the Steno Diabetes Center Copenhagen, Gentofte and RCPH, Centre for Health, Capital Region of Denmark, Denmark (T.W.H.); KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.J., T.K., L.T., J.A.S.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Denmark (J.J.); The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.K.J., K.S.S.); Research Unit Hypertension and Cardiovascular Epidemiology, Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., J.-G.W.); Institute of Internal and Preventive Medicine, Novosibirsk, Russia (T.K., S.M., Y.N.); and R & D Group VitaK, Maastricht University, The Netherlands (JAS). · Pubmed 28483916
  • aDivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical CentrebCAPHRI School for Public Health and Primary CarecDepartment of Epidemiology, Maastricht UniversitydDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The NetherlandseResearch Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, Studies Coordinating Centre, University of Leuven, Leuven, BelgiumfDepartment of Internal Medicine, Maasticht University Medical CentergCARIM School for Cardiovascular Diseases, Maastricht University Medical CentrehCARIM School for Cardiovascular Diseases, and MaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, The Netherlands. · Pubmed 28355168
2016
  • From the Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (A.P., E.B.); Department of Medical Sciences, Internal Medicine and Hypertension Division, AOU Città della Salute e della Scienza, Turin, Italy (F.R., E.B.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.); Paris-Descartes University, F-75005 Paris, France (M.A.); Assistance Publique-Hôpitaux de Paris, Hypertension Unit, Hôpital Européen Georges Pompidou, F-75015 Paris, France (M.A.); Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigations Cliniques 1418, F-75015 Paris, France (M.A.); Department of Cardiology (S.E.K.) and Department of Nephrology (A.H.), Ullevaal University Hospital, University of Oslo, Oslo, Norway; and Clinical Chemistry Department, Cliniques Universitaires St Luc, Brussels, Belgium; Louvain Center for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium (P.W, A.C.). · From the Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (A.P., E.B.); Department of Medical Sciences, Internal Medicine and Hypertension Division, AOU Città della Salute e della Scienza, Turin, Italy (F.R., E.B.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); R&D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.); Paris-Descartes University, F-75005 Paris, France (M.A.); Assistance Publique-Hôpitaux de Paris, Hypertension Unit, Hôpital Européen Georges Pompidou, F-75015 Paris, France (M.A.); Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigations Cliniques 1418, F-75015 Paris, France (M.A.); Department of Cardiology (S.E.K.) and Department of Nephrology (A.H.), Ullevaal University Hospital, University of Oslo, Oslo, Norway; and Clinical Chemistry Department, Cliniques Universitaires St Luc, Brussels, Belgium; Louvain Center for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium (P.W, A.C.). · Pubmed 27296995
  • aDivision of Rheumatology, Department of Internal Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre+, Maastricht, The Netherlands bStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium cFirst Department of Cardiology and Hypertension, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland dInstitute of Internal and Preventive Medicine, Novosibirsk, Russian Federation eDepartment of Clinical and Experimental Medicine, University of Padova, Padova fDepartment of Health Sciences, University of Milan, Milan, Italy gFaculty of Medicine, Charles University, Pilsen, Czech Republic hSchool of Nephrology, Vita-Salute San Raffaele University iInstitute of Biomedical Technologies, Italian National Centre of Research, Milan, Italy jVitaK R & D Group kDepartment of Epidemiology, CAPHRI School for Public Health and Primary Care, CARIM School for Cardiovascular Sciences, and MaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, The Netherlands. · Pubmed 27607461
  • From the Departments of Cardiology, Internal Medicine and Radiology, Isala Hospital, Zwolle, The Netherlands (M.R.d.J., A.F.H., P.G., A.A., J.J.J.S., P.P.H.M.D., A.R.R.M., B.A.A.M.v.H., J.-E.H., A.E.); Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc., Irvine, CA (E.O.Y.L.); The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Departments of Cardiology, Internal Medicine and Radiology, Isala Hospital, Zwolle, The Netherlands (M.R.d.J., A.F.H., P.G., A.A., J.J.J.S., P.P.H.M.D., A.R.R.M., B.A.A.M.v.H., J.-E.H., A.E.); Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (J.-B.l.P.d.W., A.P.); Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc., Irvine, CA (E.O.Y.L.); The Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 27113046
  • From the Pole of Cardiovascular Research (AP, LE, SH), Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium; Cardiology Department (AP, GN), Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; Human Molecular Genetics (LE, AM, MV), de Duve Institute, Université catholique de Louvain, Brussels, Belgium; Studies Coordinating Centre (YJ, W-YY, JAS), Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Population Health and Optimal Health Practices Research Unit (GN), CHU de Québec Research Centre, Québec, Canada; Pôle de recherche en Endocrinologie (DG), Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; Department of Laboratory Medicine (DG), Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium; and Research and Development VitaK Group (JAS), Maastricht University, Maastricht, The Netherlands. · Pubmed 27082544
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.N.O., L.T., A.H., F.-F.W., L.J., J.A.S.); Department of Internal Medicine, Faculty of Clinical Sciences (A.N.O.), Department of Human Physiology (J.O.O.), and Department of Chemical Pathology (M.M.N.), Faculty of Basic Clinical Sciences, College of Health Sciences, University of Abuja, Abuja, Nigeria; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina (L.S.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Department of Health, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., T.O., Y.I.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B., L.L.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O.); and R & D Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.N.O., L.T., A.H., F.-F.W., L.J., J.A.S.); Department of Internal Medicine, Faculty of Clinical Sciences (A.N.O.), Department of Human Physiology (J.O.O.), and Department of Chemical Pathology (M.M.N.), Faculty of Basic Clinical Sciences, College of Health Sciences, University of Abuja, Abuja, Nigeria; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina (L.S.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Department of Health, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., T.O., Y.I.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B., L.L.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O.); and R & D Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 27067719
2015
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (F.-F.W., A.H., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); the Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Copenhagen, Denmark (T.W.H.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (F.-F.W., A.H., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); the Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Copenhagen, Denmark (T.W.H.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25916728
  • From the Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine (S.S.F.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O'B.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Maastricht University, Maastricht, The Netherlands (J.A.S.); and Vitak Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine (S.S.F.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O'B.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Maastricht University, Maastricht, The Netherlands (J.A.S.); and Vitak Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25287401
  • From the Division of Hypertension, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Capital Federal, Argentina (L.S.A., Jessica Barochiner, J.A., P.E.C., G.D.W.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., L.J., A.N.O., J.A.S.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (José Boggia); Department of Internal Medicine, College of Health Sciences, University of Abuja, Abuja, Nigeria (A.N.O.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., K.N., T.O.); Department of Public Health, Tohoku University Graduate School of Medicine, Sendai, Japan (I.T.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (M.K., Y.I.); and R & D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Division of Hypertension, Department of Internal Medicine, Hospital Italiano de Buenos Aires, Capital Federal, Argentina (L.S.A., Jessica Barochiner, J.A., P.E.C., G.D.W.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., L.J., A.N.O., J.A.S.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (José Boggia); Department of Internal Medicine, College of Health Sciences, University of Abuja, Abuja, Nigeria (A.N.O.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., K.N., T.O.); Department of Public Health, Tohoku University Graduate School of Medicine, Sendai, Japan (I.T.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (G.S.S); Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (M.K., Y.I.); and R & D VitaK Group, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 26355122
  • aInstitute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne, Lausanne bDepartment of Cardiology cService of Nephrology, Department of Specialties, University Hospital of Geneva, Geneva dService of Nephrology, University Hospital of Lausanne, Lausanne eDepartment of Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Bern fUnit of Population Epidemiology, University Hospital of Geneva, Geneva, Switzerland gStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium hDepartment of Epidemiology, Maastricht University, Maastricht, the Netherlands iDepartment of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Japan jSwiss Institute of Bioinformatics, University of Lausanne, Lausanne kDepartment of Community Medicine and Primary Care and Emergency Medicine, University Hospital of Geneva, Geneva, Switzerland. · Pubmed 26203966
  • aResearch Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, Studies Coordinating Centre, University of Leuven, Leuven, Belgium bDepartment of Internal Medicine, Division of Cardiology, College of Health Sciences, University of Abuja cDepartment of Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria dTohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan eDepartment of Epidemiology, Maastricht University, Maastricht, The Netherlands. · Pubmed 26154854
  • From the Unit of Population Epidemiology, Department of Community Medicine and Primary Care and Emergency Medicine (I.G.), Service of Nephrology, Department of Specialties (B.P., P.-Y.M.), Department of Cardiology (G.E.), and Unit of Hypertension, Department of Community Medicine and Primary Care and Emergency Medicine (I.G., A.P.-B.), University Hospital of Geneva, Switzerland; Institute of Social and Preventive Medicine (IUMSP) (I.G., B.P., G.E., P.V., F.P., M.B.), and Department of Medicine, Service of Nephrology (M.P., M.B.), University Hospital of Lausanne, Switzerland; Department of Nephrology and Hypertension, Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Switzerland (D.A., M.M., B.V.); Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neurosciences, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Hospital of Cery, Prilly, Switzerland (N.A., C.B.E.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University Leuven, Belgium (J.S., Y.G.); Department of Epidemiology, Maastricht University, Maastricht, Netherlands (J.S.); and Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland (C.B.E.). · From the Unit of Population Epidemiology, Department of Community Medicine and Primary Care and Emergency Medicine (I.G.), Service of Nephrology, Department of Specialties (B.P., P.-Y.M.), Department of Cardiology (G.E.), and Unit of Hypertension, Department of Community Medicine and Primary Care and Emergency Medicine (I.G., A.P.-B.), University Hospital of Geneva, Switzerland; Institute of Social and Preventive Medicine (IUMSP) (I.G., B.P., G.E., P.V., F.P., M.B.), and Department of Medicine, Service of Nephrology (M.P., M.B.), University Hospital of Lausanne, Switzerland; Department of Nephrology and Hypertension, Clinic for Nephrology, Hypertension and Clinical Pharmacology, Inselspital, Bern University Hospital and University of Bern, Switzerland (D.A., M.M., B.V.); Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neurosciences, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Hospital of Cery, Prilly, Switzerland (N.A., C.B.E.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University Leuven, Belgium (J.S., Y.G.); Department of Epidemiology, Maastricht University, Maastricht, Netherlands (J.S.); and Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland (C.B.E.). · Pubmed 25489060
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.H., L.T., Y.-M.G., L.J., Z.-Y.Z., Y.-P.L., J.A.S.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Centre for Environmental Sciences, University of Hasselt, Hasselt, Belgium (T.S.N.); and Research and Development Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (A.H., L.T., Y.-M.G., L.J., Z.-Y.Z., Y.-P.L., J.A.S.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Centre for Environmental Sciences, University of Hasselt, Hasselt, Belgium (T.S.N.); and Research and Development Group VitaK, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25287397
2014
  • aPole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain bDivision of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium cAssistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou and Université Paris Descartes, Paris, France dStudies Coordinating Center, Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, Leuven, Belgium eDepartment of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden fThird Department of Internal Medicine, General Faculty Hospital, Prague, Czech Republic gDepartment of Cardiology, Ullevaal University Hospital, University of Oslo, Oslo, Norway hDepartment of Cardiology, Geneva University Hospitals, Geneva iDepartment of Nephrology, Lausanne University Hospital, Lausanne, Switzerland jBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom kDepartment of Cardiology, Isala Klinieken, Zwolle, the Netherlands lKarolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden mDepartment of Epidemiology, Maastricht University, Maastricht, the Netherlands. · Pubmed 25375391
  • From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK (P.B.M., A.F.D.); Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, PQ, Canada (E.L.S.); Director's Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (G.L.J.); Center for Epidemiological Studies and Clinical Trials, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai, China (J.-G.W.); Department of Cardiology, Ghent University, Ghent, Belgium (M.D.B.); and Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK (P.B.M., A.F.D.); Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, PQ, Canada (E.L.S.); Director's Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (G.L.J.); Center for Epidemiological Studies and Clinical Trials, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai, China (J.-G.W.); Department of Cardiology, Ghent University, Ghent, Belgium (M.D.B.); and Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25245390
  • From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.N., K.A., T.O.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (K.A., L.T., A. Hara, J.A.S.); Graduate School of Pharmaceutical Sciences (K.A., Y.I.), Tohoku Medical Megabank Organization (A. Hozawa), and Graduate School of Medicine (I.T.), Tohoku University, Sendai, Japan; Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Medicine, Turku University Hospital, Turku, Finland (T.J.N.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (I.L., J.B.); the Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (A.K., G.S.S.); and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.N., K.A., T.O.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (K.A., L.T., A. Hara, J.A.S.); Graduate School of Pharmaceutical Sciences (K.A., Y.I.), Tohoku Medical Megabank Organization (A. Hozawa), and Graduate School of Medicine (I.T.), Tohoku University, Sendai, Japan; Population Studies Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Turku, Finland (T.J.N., J.K.J., A.M.J.); Department of Medicine, Turku University Hospital, Turku, Finland (T.J.N.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (I.L., J.B.); the Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.); Hypertension Center, Third Department of Medicine, University of Athens, Sotiria Hospital, Athens, Greece (A.K., G.S.S.); and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 24980664
2012
  • Departments of Pharmacology, Maastricht University, room 4.254, Universiteitssingel 50, 6229 ER, Maastricht, The Netherlands. · Pubmed 22733471
Shanghai Jiaotong University
2017
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (C.-S.S., Y.-B.C., Q.-H.G., F.-K.L., Q.-F.H., J.-G.W., Y.L.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (F.-F.W., W.-Y.Y., L.T., J.A.S.); and R & D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (C.-S.S., Y.-B.C., Q.-H.G., F.-K.L., Q.-F.H., J.-G.W., Y.L.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (F.-F.W., W.-Y.Y., L.T., J.A.S.); and R & D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · Pubmed 27821618
2016
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (F.-F.W., Z.-Y.Z, L.T., W.-Y.Y, L.J., N.C., Y.-M.G., T.K., J.A.S.), Department of Development and Regeneration (K.A.), Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences (P.V.), University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and R&D Group VitaK (J.A.S.), Maastricht University, Maastricht, The Netherlands. · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences (F.-F.W., Z.-Y.Z, L.T., W.-Y.Y, L.J., N.C., Y.-M.G., T.K., J.A.S.), Department of Development and Regeneration (K.A.), Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences (P.V.), University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and R&D Group VitaK (J.A.S.), Maastricht University, Maastricht, The Netherlands. · Pubmed 27324224
2015
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (L.Z., Y.L., F.-F.W., Y.-Y.K., S.W., T.-Y.X., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (L.Z., Y.L., F.-F.W., Y.-Y.K., S.W., T.-Y.X., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25870194
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Y.-M.G., Y.-P.L., L.T., T.P., Z.Z., T.K., J.A.S.) and Center for Molecular and Vascular Biology (P.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (S.W., L.Z., F.-F.W., Y.-Y.K., Q.-F.H.,C.-S.S.,Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and VitaK Research and Development (J.A.S.), Maastricht University, Maastricht, The Netherlands. · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology (Y.-M.G., Y.-P.L., L.T., T.P., Z.Z., T.K., J.A.S.) and Center for Molecular and Vascular Biology (P.V.), KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (S.W., L.Z., F.-F.W., Y.-Y.K., Q.-F.H.,C.-S.S.,Y.L.); and Department of Pharmacology (H.A.J.S.-B.) and VitaK Research and Development (J.A.S.), Maastricht University, Maastricht, The Netherlands. · Pubmed 25712718
2017
  • aDepartment of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Bern, Switzerland bMount Sinai Icahn School of Medicine, New York, New York, USA cJagiellonian University Krakow, Kraków, Poland dDepartment of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Brescia, Italy eService de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland fDepartment of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, Washington gHeart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine, California, USA hDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland iDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan jDepartment of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway kCardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA lDepartment of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, Paris, France mHypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, Canada nDepartment of Heart Diseases, University of Bergen, Haukeland Hospital, Bergen, Norway oUniversity of Milano-Bicocca pIRCCS Istituto Auxologico Italiano, Milan, Italy qDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland rHypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington, District of Columbia, USA sDepartment of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano tDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy uImperial Clinical Trials Unit, Imperial College London, London, UK vHospital Clinico Unviersitario de Valencia, Valencia wDepartment of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain xDepartment of Medicine, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Québec, Canada yDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany zDivision of Nephrology and Hypertension, Department of Medicine aaAmerican Society of Hypertension, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA bbInternational Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London - Hammersmith Campus, London, UK ccDiabetes and Cardiovascular Center, University of Missouri School of Medicine ddDepartment Service, Harry S Truman Memorial Veterans Hospital eeDepartment of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri, USA ffUniversity of Leuven, Leuven, Belgium ggDepartment of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China hhSUNY Downstate Medical Center, Brooklyn, New York, USA iiUniversity College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, London, UK jjDepartment of Medicine, Masstricht University Medical Center, Maastricht University, Maastricht, the Netherlands. · Pubmed 28657972
  • From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L.); Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine (S.S.F.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland (E.O.); and R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · From the Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L.); Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California-Irvine (S.S.F.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., J.A.S.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland (E.O.); and R&D Group VitaK, Maastricht University, The Netherlands (J.A.S.). · Pubmed 28847889
  • From the Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (J.M., G.E.M.); Department of Biomedical Sciences, University of Texas Rio Grande Valley School of Medicine, Brownsville (G.E.M.); Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.A., Y.I.); Studies Coordinating Centre, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Department of Medicine, University of Padua, Italy (E.C.); the Steno Diabetes Center Copenhagen, Gentofte and RCPH, Centre for Health, Capital Region of Denmark, Denmark (T.W.H.); KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.J., T.K., L.T., J.A.S.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Denmark (J.J.); The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.K.J., K.S.S.); Research Unit Hypertension and Cardiovascular Epidemiology, Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., J.-G.W.); Institute of Internal and Preventive Medicine, Novosibirsk, Russia (T.K., S.M., Y.N.); and R & D Group VitaK, Maastricht University, The Netherlands (JAS). · From the Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (J.M., G.E.M.); Department of Biomedical Sciences, University of Texas Rio Grande Valley School of Medicine, Brownsville (G.E.M.); Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.A., Y.I.); Studies Coordinating Centre, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Department of Medicine, University of Padua, Italy (E.C.); the Steno Diabetes Center Copenhagen, Gentofte and RCPH, Centre for Health, Capital Region of Denmark, Denmark (T.W.H.); KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.J., T.K., L.T., J.A.S.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Denmark (J.J.); The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.K.J., K.S.S.); Research Unit Hypertension and Cardiovascular Epidemiology, Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., J.-G.W.); Institute of Internal and Preventive Medicine, Novosibirsk, Russia (T.K., S.M., Y.N.); and R & D Group VitaK, Maastricht University, The Netherlands (JAS). · Pubmed 28483916
2016
  • From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.). · From the Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (G.C., C.D., R.M.T., A.F.D.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (J.A.S.); Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (G.L.R.J.); and Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (J.-G.W.). · Pubmed 26711735
2015
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (F.-F.W., A.H., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); the Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Copenhagen, Denmark (T.W.H.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (F.-F.W., A.H., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A.); the Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Copenhagen, Denmark (T.W.H.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L.); and VitaK Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). · Pubmed 25916728
2014
  • From the Cardiovascular Research Institut Basel and Department of Medicine, University Hospital Basel, Basel, Switzerland (D.C., S.A., T.S.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., Y.-M.G., T.K., J.A.S.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L., J.-G.W.); Centro de Nefrologìa and Departamento de Fisiopatologìa, Hospital de Clìnicas, Universidad de la Repûblica, Montevideo, Uruguay (J.B.); Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Gentofte, Denmark (T.W.H.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., M.K., T.O., Y.I.); Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden (K.B.-B.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark (J.J.); Department of Health, Science and Technology, Aalborg University, Aalborg, Denmark (C.T.-P.); Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom (E.D.); First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakòw, Poland (K.S.-S., K.K.-J.); Department of Medicine, University of Padova, Padova, Italy (V.T., E.C.); Institute of Internal Medicine, Novosibirsk, Russian Federation (S.M., Y.N.); Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (L.L.); Asoci · Pubmed 25185130
  • From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (K.A., L.T., Y.-M.G., A.H., Y.-P.L., Z.Z., F.-F.W., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., T.O., Y.I.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L., F.-F.W., J.W.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (I.L., J.B., L. Luzardo); Departamento de Informática, Universidad Politécnica de Sinaloa, Mazatlán, Mexico (L.J.M.); Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Denmark (T.W.H.); Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (K.B.-B., L. Lind); Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden (K.B.-B.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.N., T.O.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark (J.J.); Department of Health Science and Technology, Aalborg University, Aalborg, Denmark (C.T.-P.); Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom (E.D.); First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S.-S., K.K.-J.); Department of Medicine, University of Padua, Padua, Italy (E.C.); Institute of Internal Medicine, Novosibirsk, Russian Federation (S.M., Y.N.); Faculty of Medicine, Charles University, Pilsen, Czec · Pubmed 25135185
  • From the Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L., F.-F.W., J.-G.W.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.T., Y.-M.G., Y.-P.L., T.K., J.A.S.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Tohoku University Graduate School of Pharmaceutical Sciences and Medicine, Sendai, Japan (K.A., M.K., T.O., Y.I.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Research Center for Prevention and Health and Steno Diabetes Center, Gentofte, Denmark (T.W.H.); Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden (K.B.-B.); Department of Medicine, Glostrup Hopsital, University of Copenhagen, Copenhagen, Denmark (J.J.); Copenhagen University Hospital, Copenhagen, Denmark (C.-T.P.); Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom (E.D.); First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland (K.S.-S., K.K.-J.); Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy (V.T., E.C.); Institute of Internal Medicine, Novosibirsk, Russian Federation (S.M., Y.N.); Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (L.L.); Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.); Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (L.M., G.E.M.); Faculty · Pubmed 24906822
  • Shanghai Institute of Hypertension, Shanghai Jiaotong University School of Medicine, Ruijin 2nd Rd 197, Shanghai 200025, China. · Pubmed 24396027
  • Shanghai Institute of Hypertension, Shanghai Jiaotong University School of Medicine Ruijin 2nd Rd, 197 Shanghai 200025 China. · Pubmed 24246384
2010
  • Center for Epidemiological Studies and Clinical Trials, and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Pubmed 20520575
  • Center for Epidemiologic Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Pubmed 20087326
2008
  • Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. · Pubmed 18496292
2007
  • Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University Medical School, China. · Pubmed 17984660
  • Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University Medical School, Shanghai, China. · Pubmed 17576859
Uniwersytetu Jagiellonskiego
2015
  • First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. · First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium; and Department of Epidemiology, Maastricht University, Maastricht, The Netherlands. Electronic address: · Pubmed 25704347
2017
  • aDepartment of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Bern, Switzerland bMount Sinai Icahn School of Medicine, New York, New York, USA cJagiellonian University Krakow, Kraków, Poland dDepartment of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Brescia, Italy eService de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland fDepartment of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, Washington gHeart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine, California, USA hDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland iDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan jDepartment of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway kCardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA lDepartment of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, Paris, France mHypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, Canada nDepartment of Heart Diseases, University of Bergen, Haukeland Hospital, Bergen, Norway oUniversity of Milano-Bicocca pIRCCS Istituto Auxologico Italiano, Milan, Italy qDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland rHypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington, District of Columbia, USA sDepartment of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano tDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy uImperial Clinical Trials Unit, Imperial College London, London, UK vHospital Clinico Unviersitario de Valencia, Valencia wDepartment of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain xDepartment of Medicine, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Québec, Canada yDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany zDivision of Nephrology and Hypertension, Department of Medicine aaAmerican Society of Hypertension, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA bbInternational Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London - Hammersmith Campus, London, UK ccDiabetes and Cardiovascular Center, University of Missouri School of Medicine ddDepartment Service, Harry S Truman Memorial Veterans Hospital eeDepartment of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri, USA ffUniversity of Leuven, Leuven, Belgium ggDepartment of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China hhSUNY Downstate Medical Center, Brooklyn, New York, USA iiUniversity College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, London, UK jjDepartment of Medicine, Masstricht University Medical Center, Maastricht University, Maastricht, the Netherlands. · Pubmed 28657972
  • From the Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (J.M., G.E.M.); Department of Biomedical Sciences, University of Texas Rio Grande Valley School of Medicine, Brownsville (G.E.M.); Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.A., Y.I.); Studies Coordinating Centre, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Department of Medicine, University of Padua, Italy (E.C.); the Steno Diabetes Center Copenhagen, Gentofte and RCPH, Centre for Health, Capital Region of Denmark, Denmark (T.W.H.); KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.J., T.K., L.T., J.A.S.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Denmark (J.J.); The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.K.J., K.S.S.); Research Unit Hypertension and Cardiovascular Epidemiology, Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., J.-G.W.); Institute of Internal and Preventive Medicine, Novosibirsk, Russia (T.K., S.M., Y.N.); and R & D Group VitaK, Maastricht University, The Netherlands (JAS). · From the Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela (J.M., G.E.M.); Department of Biomedical Sciences, University of Texas Rio Grande Valley School of Medicine, Brownsville (G.E.M.); Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (K.A., Y.I.); Studies Coordinating Centre, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.); Department of Medicine, University of Padua, Italy (E.C.); the Steno Diabetes Center Copenhagen, Gentofte and RCPH, Centre for Health, Capital Region of Denmark, Denmark (T.W.H.); KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (L.J., T.K., L.T., J.A.S.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Denmark (J.J.); The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.K.J., K.S.S.); Research Unit Hypertension and Cardiovascular Epidemiology, Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., J.-G.W.); Institute of Internal and Preventive Medicine, Novosibirsk, Russia (T.K., S.M., Y.N.); and R & D Group VitaK, Maastricht University, The Netherlands (JAS). · Pubmed 28483916
2016
  • aDivision of Rheumatology, Department of Internal Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre+, Maastricht, The Netherlands bStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium cFirst Department of Cardiology and Hypertension, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland dInstitute of Internal and Preventive Medicine, Novosibirsk, Russian Federation eDepartment of Clinical and Experimental Medicine, University of Padova, Padova fDepartment of Health Sciences, University of Milan, Milan, Italy gFaculty of Medicine, Charles University, Pilsen, Czech Republic hSchool of Nephrology, Vita-Salute San Raffaele University iInstitute of Biomedical Technologies, Italian National Centre of Research, Milan, Italy jVitaK R & D Group kDepartment of Epidemiology, CAPHRI School for Public Health and Primary Care, CARIM School for Cardiovascular Sciences, and MaCSBio Maastricht Centre for Systems Biology, Maastricht University, Maastricht, The Netherlands. · Pubmed 27607461
2015
  • First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, 31-501 Krakow, Poland. · Pubmed 26028239
2014
  • From the Cardiovascular Research Institut Basel and Department of Medicine, University Hospital Basel, Basel, Switzerland (D.C., S.A., T.S.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., Y.-M.G., T.K., J.A.S.); Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.L., J.-G.W.); Centro de Nefrologìa and Departamento de Fisiopatologìa, Hospital de Clìnicas, Universidad de la Repûblica, Montevideo, Uruguay (J.B.); Steno Diabetes Center, Gentofte and Research Center for Prevention and Health, Gentofte, Denmark (T.W.H.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A., M.K., T.O., Y.I.); Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden (K.B.-B.); Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.); Department of Medicine, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark (J.J.); Department of Health, Science and Technology, Aalborg University, Aalborg, Denmark (C.T.-P.); Cambridge University Hospitals, Addenbrook's Hospital, Cambridge, United Kingdom (E.D.); First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kr